| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.735 | 0.002 | 0.735 | Neuronal nicotinic receptor antagonist | 0.602 0.003 DBMET00515 0.321 0.005 DBMET00516 0.369 0.004 DBMET00519 0.681 0.003 DBMET00520 0.078 0.038 DBMET00524 0.39 0.004 DBMET00526 0.375 0.004 DBMET00533 0.321 0.005 DBMET01717 0.11 0.02 DBMET01718 0.12 0.017 DBMET00529 0.173 0.01 DBMET00527 | ||
| 0.731 | 0.003 | 0.731 | Acetylcholine nicotinic antagonist | 0.712 0.003 DBMET00515 0.331 0.006 DBMET00516 0.377 0.005 DBMET00519 0.666 0.003 DBMET00520 0.102 0.038 DBMET00524 0.4 0.005 DBMET00526 0.376 0.005 DBMET00533 0.331 0.006 DBMET01717 0.121 0.03 DBMET01718 0.134 0.025 DBMET00529 0.217 0.011 DBMET00527 | ||
| 0.693 | 0.002 | 0.693 | Nicotinic receptor alpha7 subunit antagonist | 0.515 0.002 DBMET00515 0.256 0.004 DBMET00516 0.296 0.003 DBMET00519 0.556 0.002 DBMET00520 0.073 0.02 DBMET00524 0.307 0.003 DBMET00526 0.124 0.009 DBMET00533 0.256 0.004 DBMET01717 0.094 0.013 DBMET01718 0.075 0.019 DBMET00529 0.151 0.006 DBMET00527 | ||
| 0.65 | 0.002 | 0.65 | Nicotinic alpha4beta2 receptor antagonist | 0.528 0.002 DBMET00515 0.333 0.003 DBMET00516 0.258 0.004 DBMET00519 0.631 0.002 DBMET00520 0.227 0.004 DBMET00526 0.437 0.003 DBMET00533 0.333 0.003 DBMET01717 0.15 0.008 DBMET01718 0.105 0.027 DBMET00529 0.18 0.005 DBMET00527 | ||
| 0.659 | 0.018 | 0.775 | Analgesic | 0.642 0.02 DBMET00515 0.377 0.095 DBMET00519 0.597 0.027 DBMET00520 0.312 0.132 DBMET00524 0.359 0.104 DBMET00526 0.775 0.007 DBMET00533 0.268 0.167 DBMET00529 0.232 0.2 DBMET00527 | DBMET00533 | |
| 0.572 | 0.003 | 0.587 | Acetylcholine nicotinic agonist | 0.299 0.004 DBMET00515 0.25 0.005 DBMET00516 0.311 0.004 DBMET00519 0.587 0.002 DBMET00520 0.233 0.005 DBMET00526 0.18 0.01 DBMET00533 0.25 0.005 DBMET01717 0.098 0.039 DBMET01718 0.174 0.011 DBMET00529 0.188 0.009 DBMET00527 | DBMET00520 | |
| 0.559 | 0.004 | 0.559 | Cholinergic antagonist | 0.542 0.004 DBMET00515 0.217 0.028 DBMET00516 0.347 0.01 DBMET00519 0.429 0.006 DBMET00520 0.476 0.005 DBMET00524 0.312 0.013 DBMET00526 0.358 0.01 DBMET00533 0.217 0.028 DBMET01717 0.132 0.063 DBMET01718 0.261 0.019 DBMET00529 0.239 0.023 DBMET00527 0.28 0.017 DBMET00517 | ||
| 0.557 | 0.004 | 0.557 | Acetylcholine antagonist | 0.526 0.004 DBMET00515 0.213 0.027 DBMET00516 0.345 0.01 DBMET00519 0.429 0.006 DBMET00520 0.445 0.006 DBMET00524 0.311 0.013 DBMET00526 0.267 0.017 DBMET00533 0.213 0.027 DBMET01717 0.129 0.063 DBMET01718 0.259 0.019 DBMET00529 0.236 0.023 DBMET00527 0.255 0.019 DBMET00517 | ||
| 0.535 | 0.003 | 0.535 | Acetylcholine agonist | 0.387 0.004 DBMET00515 0.232 0.01 DBMET00516 0.479 0.004 DBMET00519 0.476 0.004 DBMET00520 0.33 0.005 DBMET00526 0.281 0.006 DBMET00533 0.232 0.01 DBMET01717 0.078 0.068 DBMET01718 0.281 0.006 DBMET00529 0.378 0.004 DBMET00527 | ||
| 0.54 | 0.008 | 0.572 | Psychostimulant | 0.489 0.012 DBMET00515 0.289 0.046 DBMET00516 0.572 0.007 DBMET00519 0.472 0.014 DBMET00520 0.477 0.013 DBMET00524 0.419 0.019 DBMET00526 0.17 0.1 DBMET00533 0.289 0.046 DBMET01717 0.2 0.08 DBMET01718 0.381 0.026 DBMET00529 0.411 0.021 DBMET00527 0.499 0.011 DBMET00517 | DBMET00519 | |
| 0.536 | 0.015 | 0.619 | Nootropic | 0.619 0.009 DBMET00515 0.222 0.132 DBMET00516 0.532 0.016 DBMET00519 0.528 0.016 DBMET00520 0.458 0.026 DBMET00526 0.37 0.047 DBMET00533 0.222 0.132 DBMET01717 0.306 0.072 DBMET00529 0.21 0.145 DBMET00527 | DBMET00515 | |
| 0.537 | 0.022 | 0.542 | 5 Hydroxytryptamine release stimulant | 0.542 0.021 DBMET00515 0.295 0.071 DBMET00516 0.19 0.13 DBMET00519 0.452 0.036 DBMET00520 0.195 0.126 DBMET00526 0.295 0.071 DBMET01717 0.247 0.091 DBMET01718 0.179 0.142 DBMET00527 | DBMET00515 | |
| 0.529 | 0.023 | 0.593 | Vasodilator, peripheral | 0.39 0.058 DBMET00515 0.283 0.106 DBMET00516 0.463 0.037 DBMET00519 0.345 0.076 DBMET00520 0.593 0.017 DBMET00524 0.444 0.042 DBMET00526 0.43 0.046 DBMET00613 0.37 0.066 DBMET00643 0.283 0.106 DBMET01717 0.299 0.098 DBMET01718 0.566 0.019 DBMET00529 0.468 0.035 DBMET00527 0.507 0.026 DBMET00517 | DBMET00524 | |
| 0.495 | 0.01 | 0.516 | Sigma receptor agonist | 0.516 0.008 DBMET00515 0.158 0.08 DBMET00519 0.167 0.075 DBMET00524 0.138 0.094 DBMET00529 | DBMET00515 | |
| 0.483 | 0.002 | 0.506 | Nicotinic neuronal receptor agonist | 0.219 0.004 DBMET00515 0.164 0.005 DBMET00516 0.228 0.004 DBMET00519 0.506 0.002 DBMET00520 0.156 0.005 DBMET00526 0.115 0.01 DBMET00533 0.164 0.005 DBMET01717 0.053 0.042 DBMET01718 0.116 0.009 DBMET00529 0.108 0.011 DBMET00527 | DBMET00520 | |
| 0.478 | 0.017 | 0.509 | Potassium channel (Voltage-sensitive) blocker | 0.509 0.014 DBMET00515 0.286 0.054 DBMET00519 0.382 0.03 DBMET00520 0.154 0.133 DBMET00526 0.217 0.085 DBMET00533 | DBMET00515 | |
| 0.476 | 0.018 | 0.54 | HERG channel blocker | 0.54 0.012 DBMET00515 0.249 0.066 DBMET00519 0.381 0.031 DBMET00520 0.245 0.068 DBMET00533 0.144 0.136 DBMET00529 | DBMET00515 | |
| 0.431 | 0.003 | 0.431 | Nicotinic receptor alpha3 subunit antagonist | 0.366 0.003 DBMET00515 0.125 0.008 DBMET00516 0.18 0.005 DBMET00519 0.378 0.003 DBMET00520 0.168 0.006 DBMET00526 0.062 0.018 DBMET00533 0.125 0.008 DBMET01717 0.044 0.03 DBMET01718 0.051 0.024 DBMET00529 0.065 0.017 DBMET00527 | ||
| 0.473 | 0.047 | 0.515 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.399 0.102 DBMET00515 0.403 0.098 DBMET00516 0.502 0.033 DBMET00519 0.504 0.032 DBMET00520 0.515 0.027 DBMET00526 0.365 0.135 DBMET00533 0.338 0.164 DBMET00613 0.284 0.236 DBMET00643 0.403 0.098 DBMET01717 0.46 0.055 DBMET01718 0.351 0.149 DBMET00529 0.332 0.171 DBMET00527 | DBMET00526 | |
| 0.449 | 0.031 | 0.451 | Spasmolytic | 0.366 0.048 DBMET00515 0.165 0.15 DBMET00516 0.274 0.081 DBMET00519 0.275 0.08 DBMET00520 0.451 0.031 DBMET00524 0.172 0.143 DBMET00526 0.355 0.051 DBMET00533 0.231 0.1 DBMET00643 0.165 0.15 DBMET01717 0.334 0.058 DBMET00527 0.273 0.081 DBMET00517 | DBMET00524 | |
| 0.457 | 0.047 | 0.457 | Histamine release inhibitor | 0.292 0.128 DBMET00515 0.347 0.101 DBMET00516 0.37 0.091 DBMET00519 0.274 0.139 DBMET00520 0.216 0.185 DBMET00524 0.367 0.092 DBMET00526 0.224 0.176 DBMET00613 0.347 0.101 DBMET01717 0.225 0.176 DBMET01718 0.35 0.1 DBMET00527 | ||
| 0.387 | 0.005 | 0.387 | Dopamine agonist | 0.351 0.005 DBMET00515 0.076 0.04 DBMET00516 0.103 0.026 DBMET00519 0.13 0.018 DBMET00520 0.071 0.044 DBMET00524 0.072 0.043 DBMET00526 0.076 0.04 DBMET01717 0.175 0.012 DBMET00529 | ||
| 0.386 | 0.009 | 0.406 | NOS3 expression enhancer | 0.293 0.019 DBMET00515 0.299 0.018 DBMET00516 0.406 0.008 DBMET00519 0.271 0.022 DBMET00520 0.3 0.018 DBMET00524 0.321 0.015 DBMET00526 0.154 0.068 DBMET00533 0.299 0.018 DBMET01717 0.244 0.028 DBMET00529 0.299 0.018 DBMET00527 0.314 0.016 DBMET00517 | DBMET00519 | |
| 0.382 | 0.006 | 0.414 | Acetylcholine M1 receptor antagonist | 0.374 0.007 DBMET00515 0.188 0.048 DBMET00516 0.283 0.018 DBMET00519 0.247 0.026 DBMET00520 0.414 0.005 DBMET00524 0.164 0.063 DBMET00526 0.217 0.035 DBMET00533 0.124 0.103 DBMET00643 0.188 0.048 DBMET01717 0.143 0.081 DBMET01718 0.171 0.057 DBMET00529 0.24 0.028 DBMET00527 0.312 0.012 DBMET00517 | DBMET00524 | |
| 0.377 | 0.003 | 0.377 | Nicotinic alpha7 receptor agonist | 0.179 0.004 DBMET00515 0.129 0.005 DBMET00516 0.177 0.004 DBMET00519 0.177 0.004 DBMET00520 0.095 0.012 DBMET00526 0.098 0.011 DBMET00533 0.129 0.005 DBMET01717 0.089 0.014 DBMET00529 0.094 0.012 DBMET00527 | ||
| 0.369 | 0.002 | 0.369 | Nicotinic alpha3beta2 receptor antagonist | 0.192 0.003 DBMET00515 0.155 0.004 DBMET00516 0.135 0.004 DBMET00519 0.366 0.002 DBMET00520 0.05 0.043 DBMET00524 0.133 0.004 DBMET00526 0.233 0.003 DBMET00533 0.155 0.004 DBMET01717 0.082 0.012 DBMET01718 0.061 0.025 DBMET00529 0.126 0.005 DBMET00527 | ||
| 0.372 | 0.006 | 0.382 | 5 Hydroxytryptamine 1E antagonist | 0.382 0.005 DBMET00515 0.287 0.039 DBMET00516 0.269 0.055 DBMET00519 0.264 0.06 DBMET00520 0.203 0.127 DBMET00526 0.211 0.118 DBMET00533 0.287 0.039 DBMET01717 0.202 0.129 DBMET01718 0.215 0.113 DBMET00529 | DBMET00515 | |
| 0.362 | 0.003 | 0.396 | Nicotinic receptor alpha4 subunit antagonist | 0.318 0.003 DBMET00515 0.247 0.003 DBMET00516 0.219 0.004 DBMET00519 0.396 0.002 DBMET00520 0.088 0.011 DBMET00524 0.237 0.003 DBMET00526 0.144 0.005 DBMET00533 0.247 0.003 DBMET01717 0.057 0.024 DBMET01718 0.138 0.005 DBMET00529 0.135 0.005 DBMET00527 0.051 0.031 DBMET00517 | DBMET00520 | |
| 0.409 | 0.053 | 0.411 | MAP kinase kinase 6 inhibitor | 0.331 0.107 DBMET00516 0.338 0.102 DBMET00519 0.411 0.052 DBMET00520 0.282 0.154 DBMET00524 0.353 0.09 DBMET00526 0.3 0.135 DBMET00533 0.331 0.107 DBMET01717 0.396 0.061 DBMET01718 0.275 0.16 DBMET00529 0.292 0.144 DBMET00527 0.228 0.221 DBMET00517 | DBMET00520 | |
| 0.381 | 0.026 | 0.384 | Potassium channel blocker | 0.384 0.025 DBMET00515 0.298 0.047 DBMET00519 0.311 0.043 DBMET00520 | DBMET00515 | |
| 0.366 | 0.021 | 0.395 | 5 Hydroxytryptamine uptake stimulant | 0.359 0.023 DBMET00515 0.37 0.02 DBMET00516 0.326 0.033 DBMET00519 0.395 0.015 DBMET00520 0.302 0.044 DBMET00526 0.252 0.079 DBMET00533 0.201 0.149 DBMET00613 0.37 0.02 DBMET01717 0.236 0.096 DBMET01718 0.244 0.086 DBMET00529 0.323 0.035 DBMET00527 | DBMET00520 | |
| 0.346 | 0.005 | 0.435 | 5 Hydroxytryptamine 1F antagonist | 0.435 0.004 DBMET00515 0.064 0.055 DBMET00516 0.152 0.016 DBMET00519 0.064 0.055 DBMET01717 0.069 0.05 DBMET00529 | DBMET00515 | |
| 0.354 | 0.013 | 0.506 | Cholinergic | 0.506 0.005 DBMET00515 0.278 0.022 DBMET00519 0.289 0.02 DBMET00520 0.145 0.081 DBMET00526 0.428 0.008 DBMET00533 0.212 0.041 DBMET00529 0.183 0.055 DBMET00527 | DBMET00515 | |
| 0.37 | 0.038 | 0.37 | Calcium channel activator | 0.308 0.084 DBMET00515 0.278 0.115 DBMET00516 0.352 0.048 DBMET00519 0.344 0.054 DBMET00520 0.321 0.072 DBMET00524 0.368 0.039 DBMET00526 0.278 0.115 DBMET01717 0.25 0.147 DBMET00529 0.254 0.143 DBMET00527 0.302 0.09 DBMET00517 | ||
| 0.329 | 0.004 | 0.329 | Acetylcholine M4 receptor antagonist | 0.222 0.005 DBMET00515 0.114 0.02 DBMET00516 0.174 0.008 DBMET00519 0.12 0.018 DBMET00520 0.099 0.029 DBMET00526 0.152 0.01 DBMET00533 0.114 0.02 DBMET01717 0.1 0.028 DBMET01718 0.087 0.04 DBMET00529 0.088 0.038 DBMET00527 | ||
| 0.315 | 0.004 | 0.315 | Acetylcholine muscarinic agonist | 0.3 0.004 DBMET00515 0.102 0.017 DBMET00516 0.288 0.004 DBMET00519 0.182 0.008 DBMET00520 0.129 0.013 DBMET00526 0.169 0.008 DBMET00533 0.102 0.017 DBMET01717 0.147 0.01 DBMET00529 0.246 0.005 DBMET00527 | ||
| 0.378 | 0.071 | 0.379 | GABA C receptor rho-3 antagonist | 0.364 0.079 DBMET00515 0.374 0.074 DBMET00516 0.379 0.071 DBMET00519 0.368 0.077 DBMET00520 0.369 0.076 DBMET00526 0.224 0.18 DBMET00533 0.318 0.104 DBMET00613 0.206 0.2 DBMET00643 0.374 0.074 DBMET01717 0.372 0.075 DBMET01718 0.254 0.151 DBMET00529 0.261 0.145 DBMET00527 | DBMET00519 | |
| 0.303 | 0.004 | 0.341 | CYP2A6 inhibitor | 0.17 0.012 DBMET00515 0.251 0.004 DBMET00516 0.194 0.008 DBMET00519 0.319 0.004 DBMET00520 0.19 0.009 DBMET00526 0.137 0.02 DBMET00533 0.341 0.003 DBMET00613 0.174 0.011 DBMET00643 0.251 0.004 DBMET01717 0.1 0.036 DBMET01718 0.113 0.03 DBMET00527 | DBMET00613 | |
| 0.332 | 0.051 | 0.332 | Hypoxia-inducible factor 1 alpha inhibitor | 0.292 0.069 DBMET00515 0.18 0.178 DBMET00516 0.262 0.09 DBMET00519 0.205 0.146 DBMET00520 0.328 0.053 DBMET00524 0.18 0.178 DBMET01717 0.189 0.165 DBMET01718 0.283 0.074 DBMET00527 0.258 0.093 DBMET00517 | ||
| 0.279 | 0.001 | 0.361 | Nicotinic alpha3beta4 receptor agonist | 0.122 0.002 DBMET00515 0.14 0.002 DBMET00516 0.119 0.002 DBMET00519 0.361 0.001 DBMET00520 0.134 0.002 DBMET00526 0.077 0.003 DBMET00533 0.14 0.002 DBMET01717 0.052 0.005 DBMET01718 0.046 0.007 DBMET00529 0.071 0.003 DBMET00527 | DBMET00520 | |
| 0.284 | 0.006 | 0.387 | 5 Hydroxytryptamine 7 antagonist | 0.387 0.005 DBMET00515 | DBMET00515 | |
| 0.275 | 0.001 | 0.275 | Nicotinic alpha4beta2 receptor agonist | 0.112 0.002 DBMET00515 0.114 0.002 DBMET00516 0.093 0.003 DBMET00519 0.258 0.001 DBMET00520 0.073 0.003 DBMET00526 0.061 0.004 DBMET00533 0.114 0.002 DBMET01717 0.042 0.007 DBMET01718 0.053 0.004 DBMET00529 0.041 0.007 DBMET00527 | ||
| 0.276 | 0.004 | 0.276 | Acetylcholine M1 receptor agonist | 0.272 0.004 DBMET00515 0.083 0.015 DBMET00516 0.239 0.004 DBMET00519 0.149 0.007 DBMET00520 0.1 0.013 DBMET00526 0.139 0.008 DBMET00533 0.083 0.015 DBMET01717 0.124 0.01 DBMET00529 0.094 0.013 DBMET00527 | ||
| 0.287 | 0.015 | 0.3 | 5 Hydroxytryptamine 2B antagonist | 0.3 0.014 DBMET00515 0.14 0.046 DBMET00516 0.141 0.045 DBMET00519 0.131 0.051 DBMET00520 0.099 0.084 DBMET00533 0.14 0.046 DBMET01717 0.099 0.085 DBMET01718 | DBMET00515 | |
| 0.3 | 0.042 | 0.457 | Cyclic AMP phosphodiesterase inhibitor | 0.169 0.123 DBMET00515 0.182 0.109 DBMET00516 0.284 0.048 DBMET00519 0.188 0.103 DBMET00520 0.457 0.01 DBMET00524 0.326 0.033 DBMET00526 0.182 0.109 DBMET01717 0.207 0.089 DBMET00527 0.436 0.012 DBMET00517 | DBMET00524 | |
| 0.263 | 0.006 | 0.291 | Opioid kappa receptor antagonist | 0.291 0.005 DBMET00515 0.074 0.068 DBMET00520 0.088 0.048 DBMET00524 0.079 0.059 DBMET00527 | DBMET00515 | |
| 0.26 | 0.004 | 0.319 | Prolactin inhibitor | 0.319 0.003 DBMET00515 0.169 0.015 DBMET00516 0.154 0.021 DBMET00519 0.198 0.009 DBMET00520 0.099 0.057 DBMET00526 0.092 0.064 DBMET00533 0.169 0.015 DBMET01717 0.148 0.023 DBMET01718 0.121 0.038 DBMET00529 0.111 0.045 DBMET00527 | DBMET00515 | |
| 0.29 | 0.038 | 0.31 | Tyrosine 3 hydroxylase inhibitor | 0.31 0.029 DBMET00515 0.258 0.061 DBMET00516 0.234 0.085 DBMET00519 0.272 0.05 DBMET00520 0.21 0.119 DBMET00526 0.19 0.155 DBMET00533 0.201 0.134 DBMET00613 0.258 0.061 DBMET01717 0.231 0.089 DBMET01718 0.225 0.097 DBMET00529 0.206 0.125 DBMET00527 | DBMET00515 | |
| 0.287 | 0.036 | 0.287 | Anesthetic general | 0.233 0.058 DBMET00515 0.156 0.107 DBMET00516 0.198 0.075 DBMET00519 0.159 0.104 DBMET00520 0.146 0.118 DBMET00524 0.151 0.113 DBMET00526 0.156 0.107 DBMET01717 0.254 0.049 DBMET00527 | ||
| 0.259 | 0.014 | 0.259 | Cyclin-dependent kinase 8 inhibitor | 0.191 0.042 DBMET00515 0.212 0.029 DBMET00516 0.236 0.019 DBMET00519 0.215 0.027 DBMET00520 0.204 0.033 DBMET00526 0.135 0.097 DBMET00533 0.212 0.029 DBMET01717 0.154 0.075 DBMET01718 0.137 0.094 DBMET00529 0.175 0.056 DBMET00527 | ||
| 0.26 | 0.019 | 0.26 | Activin receptor-like kinase 2 inhibitor | 0.165 0.056 DBMET00515 0.204 0.035 DBMET00516 0.217 0.03 DBMET00519 0.235 0.024 DBMET00520 0.203 0.036 DBMET00526 0.124 0.092 DBMET00533 0.204 0.035 DBMET01717 0.124 0.091 DBMET01718 0.122 0.093 DBMET00527 | ||
| 0.253 | 0.014 | 0.339 | Acetylcholine muscarinic antagonist | 0.239 0.016 DBMET00515 0.106 0.084 DBMET00516 0.172 0.033 DBMET00519 0.137 0.053 DBMET00520 0.339 0.007 DBMET00524 0.101 0.09 DBMET00526 0.139 0.051 DBMET00533 0.106 0.084 DBMET01717 0.188 0.028 DBMET00529 0.132 0.056 DBMET00527 0.238 0.017 DBMET00517 | DBMET00524 | |
| 0.239 | 0.001 | 0.253 | Nicotinic alpha4 receptor agonist | 0.104 0.003 DBMET00515 0.111 0.003 DBMET00516 0.078 0.003 DBMET00519 0.253 0.001 DBMET00520 0.061 0.003 DBMET00526 0.038 0.004 DBMET00533 0.111 0.003 DBMET01717 0.016 0.011 DBMET01718 0.024 0.005 DBMET00529 0.017 0.01 DBMET00527 | DBMET00520 | |
| 0.291 | 0.054 | 0.48 | Superoxide dismutase inhibitor | 0.201 0.117 DBMET00515 0.252 0.073 DBMET00516 0.224 0.094 DBMET00519 0.48 0.015 DBMET00520 0.27 0.063 DBMET00526 0.21 0.106 DBMET00533 0.213 0.104 DBMET00613 0.252 0.073 DBMET01717 0.207 0.11 DBMET01718 0.191 0.127 DBMET00527 | DBMET00520 | |
| 0.24 | 0.006 | 0.241 | 5 Hydroxytryptamine 3A agonist | 0.241 0.006 DBMET00515 0.172 0.025 DBMET00516 0.179 0.022 DBMET00519 0.207 0.013 DBMET00520 0.207 0.013 DBMET00526 0.124 0.052 DBMET00533 0.172 0.025 DBMET01717 0.124 0.053 DBMET01718 0.117 0.058 DBMET00529 | DBMET00515 | |
| 0.298 | 0.066 | 0.371 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.371 0.029 DBMET00515 0.23 0.126 DBMET00516 0.259 0.098 DBMET00519 0.211 0.145 DBMET00520 0.218 0.138 DBMET00524 0.23 0.126 DBMET01717 0.289 0.072 DBMET01718 0.225 0.131 DBMET00527 0.187 0.174 DBMET00517 | DBMET00515 | |
| 0.255 | 0.024 | 0.379 | 5 Hydroxytryptamine antagonist | 0.379 0.013 DBMET00515 0.172 0.041 DBMET00516 0.111 0.07 DBMET00519 0.14 0.054 DBMET00520 0.172 0.041 DBMET01717 | DBMET00515 | |
| 0.232 | 0.005 | 0.232 | Dopamine D2 agonist | 0.228 0.005 DBMET00515 0.053 0.025 DBMET00519 0.04 0.035 DBMET00524 0.039 0.036 DBMET00526 | ||
| 0.242 | 0.016 | 0.242 | Alpha 2b adrenoreceptor antagonist | 0.24 0.016 DBMET00515 0.102 0.073 DBMET00519 0.15 0.039 DBMET00520 | ||
| 0.361 | 0.137 | 0.451 | Caspase 9 stimulant | 0.286 0.209 DBMET00515 0.315 0.178 DBMET00516 0.356 0.141 DBMET00519 0.348 0.147 DBMET00520 0.451 0.083 DBMET00524 0.371 0.13 DBMET00526 0.315 0.178 DBMET01717 0.346 0.148 DBMET01718 0.323 0.17 DBMET00527 0.444 0.086 DBMET00517 | DBMET00524 | |
| 0.226 | 0.004 | 0.306 | Acetylcholine release stimulant | 0.156 0.013 DBMET00515 0.178 0.006 DBMET00516 0.306 0.003 DBMET00519 0.172 0.008 DBMET00520 0.188 0.005 DBMET00526 0.154 0.014 DBMET00533 0.141 0.023 DBMET00613 0.118 0.051 DBMET00643 0.178 0.006 DBMET01717 0.136 0.027 DBMET01718 0.148 0.018 DBMET00529 0.149 0.017 DBMET00527 | DBMET00519 | |
| 0.22 | 0.018 | 0.22 | Antihistaminic | 0.173 0.026 DBMET00515 0.17 0.027 DBMET00520 0.129 0.039 DBMET00533 0.09 0.065 DBMET00529 | ||
| 0.204 | 0.005 | 0.245 | Dopamine D5 antagonist | 0.245 0.004 DBMET00515 0.047 0.027 DBMET00516 0.078 0.012 DBMET00519 0.054 0.023 DBMET00520 0.131 0.007 DBMET00533 0.047 0.027 DBMET01717 0.053 0.023 DBMET00529 | DBMET00515 | |
| 0.261 | 0.064 | 0.6 | Vasodilator | 0.216 0.092 DBMET00515 0.181 0.12 DBMET00519 0.174 0.128 DBMET00520 0.438 0.018 DBMET00524 0.201 0.104 DBMET00526 0.6 0.006 DBMET00613 0.576 0.007 DBMET00643 0.569 0.007 DBMET00529 0.449 0.016 DBMET00527 0.392 0.025 DBMET00517 | DBMET00613 | |
| 0.202 | 0.007 | 0.202 | Acetylcholine M2 receptor antagonist | 0.138 0.013 DBMET00515 0.06 0.045 DBMET00516 0.127 0.015 DBMET00519 0.066 0.04 DBMET00520 0.076 0.032 DBMET00533 0.06 0.045 DBMET01717 0.054 0.051 DBMET01718 0.079 0.03 DBMET00529 0.058 0.046 DBMET00527 | ||
| 0.21 | 0.016 | 0.21 | 5 Hydroxytryptamine 2C antagonist | 0.205 0.016 DBMET00515 0.1 0.045 DBMET00516 0.099 0.046 DBMET00520 0.1 0.045 DBMET01717 | ||
| 0.194 | 0.006 | 0.194 | Histamine N-methyltransferase inhibitor | 0.165 0.01 DBMET00515 0.12 0.03 DBMET00516 0.096 0.05 DBMET00519 0.128 0.024 DBMET00520 0.148 0.015 DBMET00524 0.077 0.071 DBMET00533 0.094 0.051 DBMET00613 0.12 0.03 DBMET01717 0.122 0.028 DBMET01718 0.08 0.067 DBMET00527 | ||
| 0.206 | 0.018 | 0.206 | Histamine antagonist | 0.161 0.027 DBMET00515 0.163 0.026 DBMET00520 0.121 0.038 DBMET00533 0.079 0.064 DBMET00529 | ||
| 0.244 | 0.059 | 0.322 | Anticonvulsant | 0.211 0.075 DBMET00515 0.201 0.082 DBMET00519 0.218 0.071 DBMET00520 0.214 0.073 DBMET00524 0.194 0.087 DBMET00526 0.322 0.035 DBMET00529 0.175 0.103 DBMET00517 | DBMET00529 | |
| 0.187 | 0.005 | 0.187 | Acetylcholine M5 receptor antagonist | 0.134 0.01 DBMET00515 0.065 0.036 DBMET00516 0.11 0.015 DBMET00519 0.087 0.021 DBMET00520 0.073 0.029 DBMET00526 0.081 0.024 DBMET00533 0.065 0.036 DBMET01717 0.069 0.031 DBMET01718 0.063 0.038 DBMET00527 | ||
| 0.207 | 0.029 | 0.25 | 5 Hydroxytryptamine 2 antagonist | 0.25 0.021 DBMET00515 0.088 0.082 DBMET00516 0.095 0.076 DBMET00519 0.088 0.082 DBMET01717 | DBMET00515 | |
| 0.195 | 0.019 | 0.195 | Alpha 2c adrenoreceptor antagonist | 0.17 0.025 DBMET00515 0.116 0.052 DBMET00520 | ||
| 0.202 | 0.027 | 0.23 | Neurotrophic factor | 0.139 0.07 DBMET00515 0.14 0.068 DBMET00519 0.132 0.078 DBMET00520 0.112 0.11 DBMET01718 0.23 0.016 DBMET00529 | DBMET00529 | |
| 0.21 | 0.037 | 0.21 | Tyrosine-protein kinase receptor antagonist | 0.121 0.086 DBMET00515 0.121 0.086 DBMET00516 0.182 0.048 DBMET00519 0.2 0.04 DBMET00520 0.209 0.037 DBMET00526 0.121 0.086 DBMET01717 | ||
| 0.244 | 0.074 | 0.287 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.194 0.183 DBMET00515 0.196 0.177 DBMET00516 0.213 0.131 DBMET00519 0.287 0.032 DBMET00520 0.241 0.078 DBMET00524 0.232 0.093 DBMET00526 0.196 0.177 DBMET01717 0.253 0.062 DBMET01718 0.222 0.111 DBMET00517 | DBMET00520 | |
| 0.228 | 0.059 | 0.251 | MAP kinase kinase 3 inhibitor | 0.22 0.074 DBMET00516 0.223 0.068 DBMET00519 0.247 0.034 DBMET00520 0.242 0.04 DBMET00526 0.204 0.111 DBMET00533 0.192 0.148 DBMET00613 0.22 0.074 DBMET01717 0.251 0.031 DBMET01718 0.206 0.106 DBMET00527 | DBMET01718 | |
| 0.166 | 0.004 | 0.166 | 5 Hydroxytryptamine 3 agonist | 0.114 0.01 DBMET00515 0.116 0.01 DBMET00516 0.105 0.013 DBMET00519 0.132 0.006 DBMET00520 0.103 0.014 DBMET00526 0.077 0.029 DBMET00533 0.116 0.01 DBMET01717 0.087 0.022 DBMET01718 | ||
| 0.192 | 0.032 | 0.192 | TRKA antagonist | 0.106 0.082 DBMET00515 0.121 0.066 DBMET00516 0.165 0.042 DBMET00519 0.189 0.033 DBMET00520 0.159 0.045 DBMET00526 0.121 0.066 DBMET01717 | ||
| 0.176 | 0.018 | 0.176 | Histamine H1 receptor antagonist | 0.157 0.022 DBMET00515 0.073 0.065 DBMET00519 0.153 0.023 DBMET00533 0.074 0.064 DBMET01718 0.114 0.035 DBMET00529 | ||
| 0.176 | 0.019 | 0.183 | Opioid antagonist | 0.183 0.017 DBMET00515 | DBMET00515 | |
| 0.154 | 0.002 | 0.16 | Prolactin release inhibitor | 0.16 0.002 DBMET00515 0.103 0.004 DBMET00516 0.097 0.005 DBMET00519 0.088 0.007 DBMET00520 0.098 0.005 DBMET00524 0.065 0.033 DBMET00533 0.103 0.004 DBMET01717 0.074 0.017 DBMET01718 0.087 0.007 DBMET00529 0.09 0.006 DBMET00527 0.065 0.033 DBMET00517 | DBMET00515 | |
| 0.205 | 0.054 | 0.214 | 5 Hydroxytryptamine 3E antagonist | 0.212 0.045 DBMET00515 0.176 0.118 DBMET00516 0.214 0.042 DBMET00520 0.175 0.118 DBMET00526 0.164 0.156 DBMET00533 0.176 0.118 DBMET01717 0.168 0.142 DBMET01718 | DBMET00520 | |
| 0.169 | 0.022 | 0.173 | Protein kinase C gamma inhibitor | 0.135 0.041 DBMET00515 0.137 0.04 DBMET00516 0.173 0.021 DBMET00519 0.149 0.032 DBMET00520 0.151 0.031 DBMET00526 0.137 0.04 DBMET01717 0.139 0.038 DBMET01718 0.157 0.028 DBMET00527 | DBMET00519 | |
| 0.161 | 0.014 | 0.258 | Dopamine D1 antagonist | 0.258 0.007 DBMET00515 0.059 0.051 DBMET00519 0.074 0.036 DBMET00520 0.081 0.033 DBMET00533 | DBMET00515 | |
| 0.166 | 0.019 | 0.166 | Alpha 2a adrenoreceptor antagonist | 0.133 0.026 DBMET00515 0.102 0.036 DBMET00520 | ||
| 0.248 | 0.104 | 0.248 | Ca(v)3.3 blocker | 0.2 0.192 DBMET00520 0.2 0.192 DBMET00613 | ||
| 0.15 | 0.009 | 0.15 | TRPA1 antagonist | 0.079 0.026 DBMET00515 0.077 0.027 DBMET00516 0.083 0.023 DBMET00519 0.077 0.027 DBMET01717 | ||
| 0.146 | 0.005 | 0.146 | Acetylcholine M5 receptor agonist | 0.118 0.011 DBMET00515 0.09 0.026 DBMET00516 0.143 0.005 DBMET00519 0.092 0.025 DBMET00520 0.104 0.018 DBMET00526 0.09 0.026 DBMET01717 0.083 0.032 DBMET00529 0.073 0.04 DBMET00527 | ||
| 0.164 | 0.023 | 0.187 | Dopamine antagonist | 0.187 0.02 DBMET00515 0.062 0.061 DBMET00519 0.066 0.057 DBMET00520 | DBMET00515 | |
| 0.164 | 0.024 | 0.164 | Alpha 2 adrenoreceptor antagonist | 0.14 0.03 DBMET00515 0.105 0.045 DBMET00520 | ||
| 0.161 | 0.024 | 0.187 | Antineoplastic alkaloid | 0.187 0.017 DBMET00515 0.173 0.021 DBMET00519 0.109 0.042 DBMET00524 0.117 0.039 DBMET00529 0.185 0.018 DBMET00527 0.119 0.038 DBMET00517 | DBMET00515 | |
| 0.146 | 0.011 | 0.187 | Sigma receptor antagonist | 0.187 0.009 DBMET00515 0.045 0.037 DBMET00520 | DBMET00515 | |
| 0.139 | 0.005 | 0.139 | Phosphodiesterase 1A inhibitor | 0.084 0.014 DBMET00515 0.086 0.014 DBMET00516 0.108 0.009 DBMET00519 0.064 0.033 DBMET00520 0.069 0.025 DBMET00526 0.086 0.014 DBMET01717 0.071 0.023 DBMET00529 | ||
| 0.169 | 0.036 | 0.169 | Nav1.6 sodium channel blocker | 0.118 0.099 DBMET00515 0.154 0.049 DBMET00520 0.135 0.074 DBMET00526 | ||
| 0.142 | 0.01 | 0.193 | 5 Hydroxytryptamine 3 antagonist | 0.193 0.006 DBMET00515 0.055 0.042 DBMET00519 0.055 0.041 DBMET00520 0.064 0.032 DBMET00533 | DBMET00515 | |
| 0.149 | 0.017 | 0.149 | Phosphodiesterase I inhibitor | 0.111 0.033 DBMET00515 0.097 0.048 DBMET00516 0.115 0.03 DBMET00519 0.088 0.062 DBMET00520 0.102 0.042 DBMET00524 0.093 0.054 DBMET00526 0.097 0.048 DBMET01717 0.083 0.07 DBMET00517 | ||
| 0.135 | 0.004 | 0.155 | Nicotinic receptor beta4 subunit antagonist | 0.101 0.006 DBMET00515 0.094 0.007 DBMET00516 0.092 0.007 DBMET00519 0.147 0.004 DBMET00520 0.036 0.027 DBMET00524 0.155 0.004 DBMET00526 0.062 0.012 DBMET00533 0.094 0.007 DBMET01717 0.033 0.032 DBMET01718 0.051 0.015 DBMET00529 0.058 0.013 DBMET00527 | DBMET00526 | |
| 0.136 | 0.006 | 0.136 | 5 Hydroxytryptamine 3A antagonist | 0.129 0.008 DBMET00515 0.081 0.03 DBMET00516 0.087 0.025 DBMET00519 0.09 0.022 DBMET00520 0.067 0.046 DBMET00526 0.081 0.03 DBMET01717 0.067 0.046 DBMET00529 | ||
| 0.149 | 0.024 | 0.149 | 5 Hydroxytryptamine 1 antagonist | 0.145 0.025 DBMET00515 0.074 0.05 DBMET00519 | ||
| 0.142 | 0.017 | 0.18 | Analgesic, opioid | 0.142 0.017 DBMET00515 0.18 0.011 DBMET00533 | DBMET00533 | |
| 0.152 | 0.028 | 0.174 | 5 Hydroxytryptamine 2A antagonist | 0.174 0.023 DBMET00515 | DBMET00515 | |
| 0.139 | 0.017 | 0.149 | Dopamine D3 antagonist | 0.149 0.015 DBMET00515 0.062 0.043 DBMET00516 0.058 0.047 DBMET00519 0.06 0.044 DBMET00520 0.062 0.043 DBMET01717 | DBMET00515 | |
| 0.183 | 0.062 | 0.183 | Antipruritic | 0.162 0.081 DBMET00515 0.174 0.07 DBMET00520 0.14 0.106 DBMET00526 0.137 0.111 DBMET00533 | ||
| 0.144 | 0.023 | 0.144 | Dopamine D2 antagonist | 0.133 0.025 DBMET00515 | ||
| 0.125 | 0.005 | 0.139 | Cyclin-dependent kinase 6 inhibitor | 0.087 0.017 DBMET00515 0.091 0.014 DBMET00516 0.085 0.018 DBMET00519 0.139 0.005 DBMET00520 0.089 0.015 DBMET00526 0.069 0.032 DBMET00533 0.091 0.014 DBMET01717 0.071 0.03 DBMET01718 0.063 0.038 DBMET00527 | DBMET00520 | |
| 0.138 | 0.019 | 0.138 | Dopamine D4 antagonist | 0.1 0.026 DBMET00515 0.055 0.046 DBMET00519 0.058 0.043 DBMET00520 | ||
| 0.124 | 0.006 | 0.16 | Glutamate (mGluR group I) agonist | 0.057 0.025 DBMET00515 0.074 0.014 DBMET00516 0.16 0.004 DBMET00519 0.091 0.01 DBMET00520 0.071 0.016 DBMET00526 0.074 0.014 DBMET01717 0.045 0.037 DBMET00529 0.05 0.031 DBMET00527 | DBMET00519 | |
| 0.141 | 0.022 | 0.154 | Protein kinase C zeta inhibitor | 0.097 0.054 DBMET00515 0.108 0.041 DBMET00516 0.114 0.037 DBMET00519 0.154 0.019 DBMET00520 0.105 0.045 DBMET00526 0.108 0.041 DBMET01717 0.121 0.032 DBMET01718 0.111 0.039 DBMET00527 | DBMET00520 | |
| 0.139 | 0.021 | 0.143 | Polo-like kinase-1 inhibitor | 0.093 0.056 DBMET00515 0.098 0.048 DBMET00516 0.143 0.019 DBMET00519 0.093 0.056 DBMET00520 0.104 0.041 DBMET00526 0.125 0.028 DBMET00533 0.098 0.048 DBMET01717 0.111 0.036 DBMET00529 | DBMET00519 | |
| 0.123 | 0.005 | 0.146 | Glutamate (mGluR5) agonist | 0.058 0.019 DBMET00515 0.078 0.011 DBMET00516 0.146 0.004 DBMET00519 0.09 0.009 DBMET00520 0.069 0.014 DBMET00526 0.046 0.031 DBMET00533 0.078 0.011 DBMET01717 0.049 0.027 DBMET00529 0.052 0.023 DBMET00527 | DBMET00519 | |
| 0.19 | 0.073 | 0.231 | TRKC antagonist | 0.127 0.124 DBMET00515 0.147 0.104 DBMET00519 0.163 0.091 DBMET00520 0.231 0.055 DBMET00526 | DBMET00526 | |
| 0.15 | 0.034 | 0.15 | Interleukin 8 antagonist | 0.102 0.093 DBMET00516 0.147 0.036 DBMET00520 0.102 0.093 DBMET01717 | ||
| 0.134 | 0.019 | 0.172 | Alpha adrenoreceptor agonist | 0.079 0.038 DBMET00515 0.172 0.012 DBMET00520 | DBMET00520 | |
| 0.192 | 0.078 | 0.192 | I kappa B kinase epsilon inhibitor | 0.16 0.109 DBMET00516 0.155 0.114 DBMET00519 0.191 0.079 DBMET00520 0.137 0.135 DBMET00526 0.16 0.109 DBMET01717 | ||
| 0.161 | 0.048 | 0.21 | Toll-Like receptor antagonist | 0.21 0.027 DBMET00515 0.19 0.034 DBMET00520 | DBMET00515 | |
| 0.245 | 0.131 | 0.44 | Transcription factor NF kappa B inhibitor | 0.268 0.115 DBMET00515 0.283 0.105 DBMET00519 0.391 0.065 DBMET00524 0.193 0.176 DBMET00526 0.24 0.135 DBMET00613 0.266 0.116 DBMET00643 0.28 0.107 DBMET00527 0.44 0.055 DBMET00517 | DBMET00517 | |
| 0.165 | 0.054 | 0.242 | Toll-Like receptor 9 antagonist | 0.242 0.022 DBMET00515 0.15 0.063 DBMET00520 | DBMET00515 | |
| 0.195 | 0.085 | 0.211 | MAP kinase kinase 2 inhibitor | 0.159 0.113 DBMET00516 0.174 0.101 DBMET00519 0.211 0.075 DBMET00520 0.143 0.128 DBMET00526 0.159 0.113 DBMET01717 0.159 0.114 DBMET00527 | DBMET00520 | |
| 0.118 | 0.01 | 0.135 | Alpha 2 adrenoreceptor agonist | 0.078 0.025 DBMET00515 0.054 0.052 DBMET00516 0.135 0.008 DBMET00520 0.054 0.052 DBMET01717 | DBMET00520 | |
| 0.119 | 0.01 | 0.132 | 5 Hydroxytryptamine 6 antagonist | 0.132 0.008 DBMET00515 0.078 0.024 DBMET00516 0.105 0.013 DBMET00520 0.078 0.024 DBMET01717 | DBMET00515 | |
| 0.131 | 0.023 | 0.131 | 5 Hydroxytryptamine 1A antagonist | 0.108 0.029 DBMET00515 0.069 0.047 DBMET00519 0.064 0.05 DBMET00520 | ||
| 0.13 | 0.022 | 0.139 | Opioid mu receptor antagonist | 0.139 0.02 DBMET00515 | DBMET00515 | |
| 0.125 | 0.018 | 0.125 | Phosphodiesterase XI inhibitor | 0.092 0.04 DBMET00515 0.106 0.028 DBMET00516 0.109 0.025 DBMET00519 0.112 0.024 DBMET00520 0.112 0.024 DBMET00526 0.106 0.028 DBMET01717 | ||
| 0.125 | 0.018 | 0.125 | Phosphodiesterase 11A inhibitor | 0.092 0.04 DBMET00515 0.106 0.028 DBMET00516 0.109 0.025 DBMET00519 0.112 0.024 DBMET00520 0.112 0.024 DBMET00526 0.106 0.028 DBMET01717 | ||
| 0.11 | 0.005 | 0.117 | Potassium channel small-conductance Ca-activated blocker | 0.117 0.005 DBMET00515 0.05 0.025 DBMET00516 0.048 0.026 DBMET00519 0.075 0.011 DBMET00520 0.05 0.025 DBMET01717 | DBMET00515 | |
| 0.118 | 0.014 | 0.118 | Acetylcholine M3 receptor antagonist | 0.094 0.02 DBMET00515 0.059 0.043 DBMET00519 0.077 0.028 DBMET00529 | ||
| 0.109 | 0.007 | 0.13 | Glutamate (mGluR7) antagonist | 0.077 0.032 DBMET00515 0.119 0.005 DBMET00516 0.13 0.004 DBMET00519 0.074 0.035 DBMET00520 0.094 0.014 DBMET00526 0.068 0.046 DBMET00533 0.119 0.005 DBMET01717 0.089 0.018 DBMET01718 0.085 0.022 DBMET00529 0.111 0.006 DBMET00527 | DBMET00519 | |
| 0.111 | 0.009 | 0.111 | Protein kinase C beta inhibitor | 0.101 0.013 DBMET00515 0.077 0.034 DBMET00516 0.087 0.022 DBMET00519 0.103 0.012 DBMET00520 0.107 0.011 DBMET00524 0.088 0.021 DBMET00526 0.077 0.034 DBMET01717 0.083 0.026 DBMET01718 0.081 0.029 DBMET00527 0.083 0.026 DBMET00517 | ||
| 0.147 | 0.049 | 0.147 | TRKB antagonist | 0.112 0.084 DBMET00515 0.114 0.081 DBMET00519 0.114 0.081 DBMET00520 0.123 0.07 DBMET00526 | ||
| 0.113 | 0.019 | 0.113 | 5 Hydroxytryptamine 1B antagonist | 0.113 0.019 DBMET00515 0.058 0.054 DBMET00519 | ||
| 0.107 | 0.014 | 0.107 | 5 Hydroxytryptamine 5 antagonist | 0.07 0.026 DBMET00515 | ||
| 0.095 | 0.005 | 0.119 | 5 Hydroxytryptamine 3B antagonist | 0.119 0.004 DBMET00515 0.039 0.022 DBMET00516 0.042 0.019 DBMET00519 0.035 0.026 DBMET00520 0.039 0.022 DBMET01717 | DBMET00515 | |
| 0.159 | 0.069 | 0.225 | Cytidine deaminase inhibitor | 0.219 0.039 DBMET00515 0.136 0.086 DBMET00519 0.225 0.037 DBMET00524 0.128 0.093 DBMET00527 0.204 0.046 DBMET00517 | DBMET00524 | |
| 0.199 | 0.11 | 0.607 | Tumour necrosis factor alpha release inhibitor | 0.219 0.093 DBMET00519 0.297 0.054 DBMET00526 0.418 0.024 DBMET00533 0.607 0.007 DBMET00529 0.335 0.042 DBMET00527 | DBMET00529 | |
| 0.104 | 0.015 | 0.104 | 5 Hydroxytryptamine 5A antagonist | 0.079 0.024 DBMET00515 | ||
| 0.144 | 0.055 | 0.249 | Glutamate receptor antagonist | 0.106 0.089 DBMET00515 0.249 0.016 DBMET00520 0.211 0.023 DBMET00526 0.104 0.091 DBMET00529 | DBMET00520 | |
| 0.091 | 0.003 | 0.091 | 5 Hydroxytryptamine 6 agonist | 0.09 0.003 DBMET00515 0.043 0.006 DBMET00516 0.032 0.014 DBMET00519 0.052 0.004 DBMET00520 0.029 0.018 DBMET00533 0.043 0.006 DBMET01717 0.03 0.018 DBMET01718 | ||
| 0.097 | 0.009 | 0.097 | Histamine agonist | 0.06 0.027 DBMET00515 0.087 0.012 DBMET00520 0.047 0.045 DBMET00526 | ||
| 0.1 | 0.013 | 0.11 | Orexin receptor 1 antagonist | 0.079 0.036 DBMET00515 0.075 0.043 DBMET00516 0.11 0.009 DBMET00519 0.072 0.048 DBMET00520 0.076 0.042 DBMET00526 0.075 0.043 DBMET01717 0.083 0.031 DBMET00527 | DBMET00519 | |
| 0.191 | 0.104 | 0.272 | Nitric-oxide synthase stimulant | 0.198 0.092 DBMET00516 0.209 0.074 DBMET00519 0.252 0.031 DBMET00520 0.272 0.02 DBMET00526 0.183 0.121 DBMET00533 0.223 0.057 DBMET00613 0.243 0.037 DBMET00643 0.198 0.092 DBMET01717 0.173 0.144 DBMET01718 0.249 0.033 DBMET00529 0.233 0.046 DBMET00527 | DBMET00526 | |
| 0.106 | 0.02 | 0.115 | 5 Hydroxytryptamine 1D antagonist | 0.115 0.018 DBMET00515 | DBMET00515 | |
| 0.115 | 0.029 | 0.239 | Glutamate receptor agonist | 0.239 0.007 DBMET00519 0.091 0.044 DBMET00520 0.089 0.045 DBMET00526 | DBMET00519 | |
| 0.096 | 0.011 | 0.096 | Potassium channel (Tandem pore domain) blocker | 0.086 0.022 DBMET00515 0.076 0.046 DBMET00516 0.072 0.056 DBMET00519 0.083 0.028 DBMET00520 0.076 0.046 DBMET01717 | ||
| 0.107 | 0.026 | 0.107 | mTOR complex 2 inhibitor | 0.087 0.052 DBMET00515 0.085 0.057 DBMET00516 0.08 0.068 DBMET00519 0.106 0.027 DBMET00520 0.088 0.052 DBMET00526 0.085 0.057 DBMET01717 | ||
| 0.105 | 0.024 | 0.109 | Cyclin-dependent kinase 4 inhibitor | 0.076 0.037 DBMET00515 0.063 0.048 DBMET00516 0.064 0.046 DBMET00519 0.109 0.022 DBMET00520 0.069 0.042 DBMET00526 0.063 0.048 DBMET01717 | DBMET00520 | |
| 0.094 | 0.015 | 0.104 | Orexin receptor antagonist | 0.075 0.033 DBMET00515 0.064 0.051 DBMET00516 0.104 0.01 DBMET00519 0.061 0.057 DBMET00526 0.064 0.051 DBMET01717 0.07 0.041 DBMET00527 | DBMET00519 | |
| 0.115 | 0.036 | 0.115 | mTOR complex 1 inhibitor | 0.096 0.071 DBMET00516 0.093 0.078 DBMET00519 0.096 0.071 DBMET01717 | ||
| 0.144 | 0.065 | 0.144 | Pregnane X receptor agonist | 0.13 0.101 DBMET00515 0.131 0.098 DBMET00516 0.123 0.121 DBMET00519 0.126 0.11 DBMET00520 0.131 0.098 DBMET01717 | ||
| 0.084 | 0.005 | 0.104 | Acetylcholine M4 receptor agonist | 0.062 0.009 DBMET00515 0.034 0.019 DBMET00516 0.104 0.004 DBMET00519 0.043 0.014 DBMET00520 0.082 0.005 DBMET00526 0.034 0.019 DBMET01717 0.039 0.015 DBMET00529 0.038 0.016 DBMET00527 | DBMET00519 | |
| 0.101 | 0.024 | 0.101 | Polo-like kinase-2 inhibitor | 0.074 0.049 DBMET00515 0.091 0.034 DBMET00516 0.099 0.026 DBMET00519 0.066 0.057 DBMET00520 0.091 0.034 DBMET01717 | ||
| 0.106 | 0.029 | 0.112 | Opioid delta receptor antagonist | 0.112 0.028 DBMET00515 | DBMET00515 | |
| 0.108 | 0.032 | 0.123 | Bromodomain-containing protein 2 inhibitor | 0.115 0.027 DBMET00515 0.103 0.036 DBMET00516 0.123 0.021 DBMET00519 0.091 0.053 DBMET00520 0.107 0.033 DBMET00526 0.103 0.036 DBMET01717 | DBMET00519 | |
| 0.101 | 0.026 | 0.101 | Glutamate (mGluR group I) antagonist | 0.07 0.048 DBMET00516 0.091 0.03 DBMET00519 0.064 0.057 DBMET00526 0.07 0.048 DBMET01717 0.066 0.054 DBMET00529 | ||
| 0.142 | 0.067 | 0.155 | Ca2+-transporting ATPase inhibitor | 0.146 0.053 DBMET00515 0.146 0.053 DBMET00516 0.141 0.069 DBMET00519 0.135 0.097 DBMET00520 0.134 0.099 DBMET00526 0.146 0.053 DBMET01717 0.14 0.073 DBMET01718 0.133 0.105 DBMET00529 0.155 0.033 DBMET00527 | DBMET00527 | |
| 0.11 | 0.036 | 0.124 | Phosphodiesterase 6D inhibitor | 0.098 0.056 DBMET00516 0.124 0.022 DBMET00519 0.101 0.05 DBMET00520 0.088 0.082 DBMET00524 0.122 0.023 DBMET00526 0.098 0.056 DBMET01717 0.097 0.059 DBMET01718 0.101 0.05 DBMET00527 0.1 0.053 DBMET00517 | DBMET00519 | |
| 0.094 | 0.02 | 0.094 | Dopamine uptake inhibitor | 0.094 0.02 DBMET00515 0.071 0.029 DBMET00520 0.06 0.038 DBMET01718 | ||
| 0.097 | 0.023 | 0.136 | Toll-Like receptor 7 antagonist | 0.089 0.029 DBMET00515 0.136 0.008 DBMET00520 | DBMET00520 | |
| 0.092 | 0.019 | 0.092 | Alpha 1 adrenoreceptor agonist | 0.061 0.035 DBMET00515 0.058 0.038 DBMET00520 | ||
| 0.167 | 0.094 | 0.19 | MAP kinase kinase 5 inhibitor | 0.152 0.143 DBMET00515 0.19 0.046 DBMET00520 0.164 0.101 DBMET00526 0.152 0.146 DBMET01718 | DBMET00520 | |
| 0.15 | 0.077 | 0.181 | Diuretic | 0.132 0.093 DBMET00519 0.181 0.053 DBMET01718 | DBMET01718 | |
| 0.198 | 0.126 | 0.492 | DNA synthesis inhibitor | 0.209 0.11 DBMET00515 0.186 0.145 DBMET00516 0.229 0.084 DBMET00519 0.276 0.053 DBMET00520 0.451 0.017 DBMET00524 0.277 0.052 DBMET00526 0.172 0.165 DBMET00533 0.295 0.045 DBMET00613 0.279 0.051 DBMET00643 0.186 0.145 DBMET01717 0.225 0.088 DBMET00529 0.248 0.067 DBMET00527 0.492 0.014 DBMET00517 | DBMET00517 | |
| 0.086 | 0.015 | 0.086 | Phosphodiesterase 1C inhibitor | 0.06 0.048 DBMET00515 0.063 0.041 DBMET00516 0.072 0.027 DBMET00519 0.063 0.041 DBMET01717 | ||
| 0.089 | 0.019 | 0.089 | CDK4/cyclin D1 inhibitor | 0.071 0.03 DBMET00515 0.054 0.044 DBMET00516 0.061 0.038 DBMET00519 0.086 0.02 DBMET00520 0.062 0.037 DBMET00526 0.054 0.044 DBMET01717 | ||
| 0.074 | 0.005 | 0.074 | Nerve growth factor antagonist | 0.066 0.007 DBMET00515 0.059 0.01 DBMET00516 0.063 0.008 DBMET00519 0.054 0.014 DBMET00520 0.054 0.014 DBMET00526 0.047 0.023 DBMET00533 0.059 0.01 DBMET01717 0.051 0.017 DBMET01718 0.041 0.033 DBMET00529 | ||
| 0.221 | 0.153 | 0.404 | Antithrombotic | 0.195 0.184 DBMET00520 0.404 0.048 DBMET00524 0.191 0.188 DBMET00526 0.196 0.182 DBMET00643 0.263 0.116 DBMET00527 0.337 0.069 DBMET00517 | DBMET00524 | |
| 0.183 | 0.115 | 0.189 | Aldehyde oxidase inhibitor | 0.189 0.111 DBMET00515 | DBMET00515 | |
| 0.12 | 0.052 | 0.208 | Activin receptor-like kinase 4 inhibitor | 0.112 0.063 DBMET00516 0.103 0.079 DBMET00519 0.208 0.012 DBMET00520 0.129 0.042 DBMET00526 0.112 0.063 DBMET01717 0.101 0.084 DBMET01718 | DBMET00520 | |
| 0.21 | 0.142 | 0.273 | Insulysin inhibitor | 0.193 0.168 DBMET00515 0.192 0.17 DBMET00519 0.273 0.077 DBMET00520 0.263 0.085 DBMET00526 0.195 0.165 DBMET01718 0.225 0.123 DBMET00529 | DBMET00520 | |
| 0.083 | 0.016 | 0.168 | Dopamine transporter inhibitor | 0.082 0.016 DBMET00515 0.078 0.018 DBMET00520 0.168 0.005 DBMET01718 0.055 0.028 DBMET00527 | DBMET01718 | |
| 0.098 | 0.031 | 0.122 | Caspase 7 inhibitor | 0.122 0.014 DBMET00515 0.078 0.065 DBMET00516 0.102 0.026 DBMET00519 0.091 0.039 DBMET00520 0.076 0.07 DBMET00526 0.078 0.065 DBMET01717 | DBMET00515 | |
| 0.081 | 0.014 | 0.081 | Glutamate (mGluR5) antagonist | 0.059 0.023 DBMET00516 0.064 0.02 DBMET00519 0.059 0.023 DBMET01717 | ||
| 0.086 | 0.019 | 0.086 | Phosphodiesterase 1B inhibitor | 0.054 0.052 DBMET00516 0.063 0.038 DBMET00519 0.054 0.052 DBMET01717 | ||
| 0.071 | 0.006 | 0.071 | 5 Hydroxytryptamine 1D agonist | 0.057 0.008 DBMET00515 0.028 0.02 DBMET00520 | ||
| 0.095 | 0.029 | 0.106 | Transforming growth factor beta 3 antagonist | 0.083 0.054 DBMET00516 0.078 0.071 DBMET00519 0.094 0.031 DBMET00520 0.106 0.018 DBMET00533 0.083 0.054 DBMET01717 | DBMET00533 | |
| 0.134 | 0.07 | 0.185 | Death-associated protein kinase 1 inhibitor | 0.126 0.092 DBMET00516 0.132 0.075 DBMET00519 0.185 0.011 DBMET00520 0.146 0.046 DBMET00526 0.145 0.047 DBMET00613 0.126 0.092 DBMET01717 0.133 0.074 DBMET01718 | DBMET00520 | |
| 0.149 | 0.085 | 0.275 | Polo-like kinase-3 inhibitor | 0.163 0.071 DBMET00519 0.135 0.103 DBMET00520 0.275 0.017 DBMET00533 | DBMET00533 | |
| 0.077 | 0.013 | 0.077 | Opioid kappa receptor agonist | 0.072 0.014 DBMET00515 0.043 0.03 DBMET00533 | ||
| 0.14 | 0.076 | 0.171 | Heat shock protein 70 antagonist | 0.139 0.079 DBMET00515 0.135 0.095 DBMET00516 0.136 0.091 DBMET00519 0.171 0.017 DBMET00524 0.135 0.095 DBMET01717 0.144 0.063 DBMET00527 0.166 0.021 DBMET00517 | DBMET00524 | |
| 0.191 | 0.129 | 0.371 | Interleukin agonist | 0.203 0.118 DBMET00515 0.275 0.062 DBMET00519 0.231 0.093 DBMET00520 0.293 0.051 DBMET00524 0.305 0.045 DBMET00526 0.241 0.086 DBMET00529 0.371 0.024 DBMET00517 | DBMET00517 | |
| 0.076 | 0.014 | 0.121 | 5 Hydroxytryptamine 4 antagonist | 0.121 0.004 DBMET00515 | DBMET00515 | |
| 0.127 | 0.067 | 0.136 | Nav1.3 sodium channel blocker | 0.136 0.059 DBMET00515 0.103 0.094 DBMET00520 | DBMET00515 | |
| 0.103 | 0.043 | 0.129 | Pim-3 kinase inhibitor | 0.129 0.026 DBMET00520 0.085 0.067 DBMET00526 | DBMET00520 | |
| 0.118 | 0.058 | 0.169 | Polo-like kinase-4 inhibitor | 0.169 0.026 DBMET00519 0.109 0.067 DBMET00520 0.126 0.052 DBMET00526 0.118 0.058 DBMET00529 | DBMET00519 | |
| 0.204 | 0.144 | 0.221 | Gastrin inhibitor | 0.191 0.163 DBMET00519 0.221 0.118 DBMET00520 | DBMET00520 | |
| 0.102 | 0.044 | 0.106 | Alpha 2d adrenoreceptor antagonist | 0.102 0.045 DBMET00515 0.106 0.039 DBMET00520 | DBMET00520 | |
| 0.077 | 0.02 | 0.077 | Opioid agonist | 0.07 0.023 DBMET00515 | ||
| 0.083 | 0.025 | 0.09 | 5 Hydroxytryptamine 2A agonist | 0.08 0.028 DBMET00515 0.057 0.05 DBMET00519 0.09 0.019 DBMET00520 0.086 0.022 DBMET00526 | DBMET00520 | |
| 0.076 | 0.019 | 0.124 | Toll-Like receptor 8 antagonist | 0.054 0.037 DBMET00515 0.124 0.005 DBMET00520 0.053 0.037 DBMET00526 | DBMET00520 | |
| 0.122 | 0.065 | 0.129 | Anesthetic local | 0.129 0.061 DBMET00515 | DBMET00515 | |
| 0.074 | 0.018 | 0.074 | Histamine H3 receptor antagonist | 0.038 0.036 DBMET00515 0.069 0.019 DBMET00520 | ||
| 0.069 | 0.013 | 0.084 | Histamine H4 receptor antagonist | 0.056 0.023 DBMET00515 0.084 0.008 DBMET00520 | DBMET00520 | |
| 0.078 | 0.023 | 0.078 | CDK4/cyclin D inhibitor | 0.058 0.041 DBMET00515 0.054 0.047 DBMET00516 0.059 0.04 DBMET00519 0.074 0.024 DBMET00520 0.059 0.04 DBMET00526 0.054 0.047 DBMET01717 | ||
| 0.107 | 0.052 | 0.136 | Alpha adrenoreceptor antagonist | 0.136 0.042 DBMET00515 | DBMET00515 | |
| 0.073 | 0.018 | 0.083 | 5 Hydroxytryptamine 2 agonist | 0.08 0.015 DBMET00515 0.083 0.014 DBMET00520 0.057 0.03 DBMET00526 | DBMET00520 | |
| 0.092 | 0.04 | 0.097 | Glutamate (mGluR) antagonist | 0.097 0.037 DBMET00519 0.072 0.058 DBMET00526 | DBMET00519 | |
| 0.139 | 0.089 | 0.184 | GABA C receptor rho-2 antagonist | 0.134 0.099 DBMET00515 0.142 0.085 DBMET00516 0.143 0.084 DBMET00519 0.184 0.039 DBMET00520 0.162 0.059 DBMET00526 0.142 0.085 DBMET01717 0.135 0.097 DBMET01718 | DBMET00520 | |
| 0.059 | 0.009 | 0.081 | 5 Hydroxytryptamine 2B agonist | 0.046 0.017 DBMET00515 0.038 0.028 DBMET00516 0.041 0.023 DBMET00519 0.081 0.005 DBMET00520 0.057 0.009 DBMET00526 0.038 0.028 DBMET01717 | DBMET00520 | |
| 0.059 | 0.009 | 0.059 | Histamine H1 receptor agonist | 0.053 0.014 DBMET00515 0.049 0.02 DBMET00516 0.042 0.035 DBMET00519 0.055 0.012 DBMET00520 0.043 0.033 DBMET00526 0.049 0.02 DBMET01717 | ||
| 0.07 | 0.02 | 0.07 | Opioid mu receptor agonist | 0.062 0.023 DBMET00515 | ||
| 0.069 | 0.02 | 0.075 | 5 Hydroxytryptamine 7 agonist | 0.075 0.016 DBMET00515 0.057 0.037 DBMET00519 | DBMET00515 | |
| 0.076 | 0.027 | 0.101 | Potassium channel Kv1.5 blocker | 0.101 0.018 DBMET00519 0.066 0.032 DBMET00520 0.088 0.022 DBMET00526 | DBMET00519 | |
| 0.057 | 0.008 | 0.057 | Sigma 2 receptor antagonist | 0.056 0.009 DBMET00515 | ||
| 0.053 | 0.004 | 0.053 | Dopamine D1 agonist | 0.045 0.005 DBMET00515 0.024 0.014 DBMET00516 0.022 0.018 DBMET00519 0.033 0.008 DBMET00520 0.026 0.012 DBMET00524 0.024 0.014 DBMET01717 | ||
| 0.112 | 0.065 | 0.127 | Nav1.5 sodium channel blocker | 0.11 0.068 DBMET00515 0.127 0.047 DBMET00520 0.123 0.051 DBMET00526 | DBMET00520 | |
| 0.074 | 0.027 | 0.074 | 5 Hydroxytryptamine 1 agonist | 0.063 0.031 DBMET00515 | ||
| 0.107 | 0.06 | 0.271 | GABA C receptor agonist | 0.11 0.057 DBMET00515 0.102 0.065 DBMET00516 0.091 0.077 DBMET00519 0.271 0.011 DBMET00520 0.178 0.025 DBMET00526 0.09 0.079 DBMET00613 0.091 0.077 DBMET00643 0.102 0.065 DBMET01717 0.118 0.051 DBMET01718 | DBMET00520 | |
| 0.069 | 0.022 | 0.069 | mTOR inhibitor | 0.047 0.042 DBMET00516 0.054 0.034 DBMET00520 0.047 0.042 DBMET01717 | ||
| 0.101 | 0.054 | 0.101 | HIV-1 integrase (Overall Integration) inhibitor | 0.098 0.056 DBMET00515 0.097 0.058 DBMET00520 | ||
| 0.18 | 0.134 | 0.46 | DNA damaging | 0.236 0.089 DBMET00515 0.19 0.124 DBMET00520 0.231 0.092 DBMET00524 0.185 0.129 DBMET00526 0.46 0.018 DBMET00613 0.345 0.042 DBMET00643 0.187 0.126 DBMET00517 | DBMET00613 | |
| 0.095 | 0.048 | 0.174 | Acetylcholine M3 receptor agonist | 0.092 0.05 DBMET00515 0.174 0.009 DBMET00519 0.09 0.051 DBMET00520 0.163 0.013 DBMET00526 0.163 0.013 DBMET00529 0.104 0.043 DBMET00527 0.086 0.055 DBMET00517 | DBMET00519 | |
| 0.085 | 0.039 | 0.085 | 5 Hydroxytryptamine agonist | 0.084 0.04 DBMET00515 0.064 0.051 DBMET00520 | ||
| 0.072 | 0.026 | 0.072 | Cyclin D1 inhibitor | 0.062 0.04 DBMET00515 0.062 0.039 DBMET00516 0.069 0.03 DBMET00519 0.062 0.039 DBMET00520 0.061 0.04 DBMET00526 0.062 0.039 DBMET01717 0.055 0.051 DBMET01718 | ||
| 0.054 | 0.008 | 0.054 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | 0.035 0.013 DBMET00515 0.034 0.014 DBMET00516 0.034 0.014 DBMET00519 0.034 0.014 DBMET01717 0.026 0.021 DBMET00527 | ||
| 0.058 | 0.012 | 0.07 | Alpha 1d adrenoreceptor agonist | 0.04 0.025 DBMET00515 0.05 0.016 DBMET00516 0.07 0.007 DBMET00520 0.038 0.027 DBMET00526 0.05 0.016 DBMET01717 0.049 0.017 DBMET01718 | DBMET00520 | |
| 0.056 | 0.011 | 0.072 | Orexin receptor 2 antagonist | 0.038 0.023 DBMET00515 0.072 0.007 DBMET00519 0.036 0.025 DBMET00527 | DBMET00519 | |
| 0.22 | 0.176 | 0.408 | Immunosuppressant | 0.296 0.117 DBMET00520 0.322 0.102 DBMET00524 0.262 0.139 DBMET00613 0.395 0.065 DBMET00643 0.408 0.06 DBMET01718 0.204 0.193 DBMET00527 0.291 0.121 DBMET00517 | DBMET01718 | |
| 0.047 | 0.003 | 0.054 | NMDA receptor phencyclidine site antagonist | 0.047 0.003 DBMET00515 0.017 0.009 DBMET00516 0.054 0.003 DBMET00520 0.017 0.009 DBMET01717 | DBMET00520 | |
| 0.09 | 0.047 | 0.1 | Histamine H2 receptor antagonist | 0.1 0.035 DBMET00515 | DBMET00515 | |
| 0.14 | 0.098 | 0.142 | Heat shock protein 90 alpha antagonist | 0.142 0.096 DBMET00526 0.136 0.104 DBMET00529 | DBMET00526 | |
| 0.106 | 0.064 | 0.106 | Falcipain 3 inhibitor | 0.101 0.069 DBMET00515 0.099 0.071 DBMET00613 | ||
| 0.148 | 0.107 | 0.161 | Neurotensin receptor agonist | 0.161 0.078 DBMET00515 0.16 0.08 DBMET00520 0.159 0.081 DBMET00526 | DBMET00515 | |
| 0.063 | 0.023 | 0.073 | 5 Hydroxytryptamine 1B agonist | 0.073 0.016 DBMET00515 | DBMET00515 | |
| 0.127 | 0.088 | 0.127 | CDC-like kinase 1 inhibitor | 0.115 0.1 DBMET00519 | ||
| 0.069 | 0.03 | 0.081 | Corticotropin releasing factor 2 receptor antagonist | 0.057 0.052 DBMET00515 0.058 0.051 DBMET00516 0.081 0.016 DBMET00519 0.069 0.029 DBMET00520 0.081 0.017 DBMET00526 0.058 0.051 DBMET01717 | DBMET00526 | |
| 0.098 | 0.059 | 0.156 | Protein kinase C mu inhibitor | 0.124 0.039 DBMET00520 0.081 0.079 DBMET00526 0.156 0.023 DBMET01718 | DBMET01718 | |
| 0.053 | 0.014 | 0.053 | Baculoviral IAP repeat-containing protein inhibitor | 0.049 0.023 DBMET00515 0.047 0.028 DBMET00516 0.051 0.019 DBMET00519 0.047 0.029 DBMET00520 0.049 0.024 DBMET00526 0.047 0.028 DBMET01717 | ||
| 0.066 | 0.029 | 0.066 | Fatty acid synthase inhibitor | 0.058 0.038 DBMET00519 0.051 0.05 DBMET00526 0.051 0.05 DBMET00529 | ||
| 0.08 | 0.045 | 0.08 | Rho-associated kinase II inhibitor | 0.067 0.06 DBMET00520 | ||
| 0.05 | 0.016 | 0.05 | TRPM8 blocker | 0.034 0.033 DBMET00519 0.035 0.031 DBMET00520 | ||
| 0.097 | 0.063 | 0.102 | Creatine kinase inhibitor | 0.102 0.057 DBMET00515 0.1 0.06 DBMET00516 0.092 0.069 DBMET00519 0.088 0.074 DBMET00520 0.084 0.08 DBMET00526 0.1 0.06 DBMET01717 0.102 0.057 DBMET00527 | DBMET00527 | |
| 0.058 | 0.025 | 0.058 | Potassium channel (Inward rectifier) blocker | 0.055 0.028 DBMET00520 | ||
| 0.098 | 0.065 | 0.158 | GABA C receptor rho-1 antagonist | 0.096 0.068 DBMET00515 0.097 0.066 DBMET00516 0.091 0.076 DBMET00519 0.158 0.018 DBMET00520 0.12 0.04 DBMET00526 0.097 0.066 DBMET01717 | DBMET00520 | |
| 0.118 | 0.085 | 0.118 | Nav1.2 sodium channel blocker | |||
| 0.079 | 0.047 | 0.079 | MAP kinase 7 inhibitor | 0.074 0.069 DBMET00515 | ||
| 0.112 | 0.079 | 0.135 | Cyclin-dependent kinase inhibitor | 0.135 0.064 DBMET00520 0.118 0.075 DBMET00526 | DBMET00520 | |
| 0.039 | 0.007 | 0.039 | 5 Hydroxytryptamine 1F agonist | 0.033 0.01 DBMET00515 0.024 0.019 DBMET00529 | ||
| 0.084 | 0.052 | 0.084 | CC chemokine 5 receptor agonist | 0.082 0.058 DBMET00515 0.084 0.05 DBMET00520 0.081 0.06 DBMET00529 | ||
| 0.096 | 0.064 | 0.131 | Electrolyte absorption antagonist | 0.094 0.067 DBMET00516 0.131 0.029 DBMET00519 0.103 0.054 DBMET00520 0.118 0.038 DBMET00526 0.094 0.067 DBMET01717 0.116 0.039 DBMET01718 | DBMET00519 | |
| 0.085 | 0.055 | 0.085 | GABA A receptor agonist | 0.081 0.061 DBMET00520 | ||
| 0.076 | 0.045 | 0.076 | MAP3K7 inhibitor | 0.067 0.059 DBMET00515 0.068 0.058 DBMET00520 | ||
| 0.072 | 0.042 | 0.125 | CDC7 inhibitor | 0.066 0.049 DBMET00519 0.125 0.014 DBMET00520 0.112 0.018 DBMET00526 | DBMET00520 | |
| 0.091 | 0.061 | 0.156 | Protein kinase C delta inhibitor | 0.156 0.019 DBMET00520 0.096 0.056 DBMET00533 0.087 0.066 DBMET01718 | DBMET00520 | |
| 0.042 | 0.014 | 0.042 | Ceramide glucosyltransferase inhibitor | 0.034 0.028 DBMET00515 0.032 0.031 DBMET00520 0.036 0.024 DBMET00524 0.035 0.025 DBMET01718 0.035 0.026 DBMET00527 | ||
| 0.113 | 0.085 | 0.2 | Alpha-N-acetylglucosaminidase inhibitor | 0.128 0.07 DBMET00515 0.12 0.078 DBMET00516 0.114 0.083 DBMET00519 0.158 0.051 DBMET00520 0.12 0.078 DBMET00524 0.16 0.049 DBMET00526 0.12 0.078 DBMET01717 0.2 0.034 DBMET00527 0.114 0.083 DBMET00517 | DBMET00527 | |
| 0.105 | 0.077 | 0.134 | Interleukin 2 antagonist | 0.111 0.061 DBMET00519 0.134 0.029 DBMET00526 | DBMET00526 | |
| 0.037 | 0.01 | 0.092 | DNA topoisomerase IV inhibitor | 0.034 0.013 DBMET00516 0.037 0.01 DBMET00519 0.092 0.004 DBMET00520 0.053 0.005 DBMET00526 0.029 0.025 DBMET00533 0.034 0.013 DBMET01717 | DBMET00520 | |
| 0.063 | 0.037 | 0.063 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.245 | 0.22 | 0.504 | Apoptosis agonist | 0.32 0.158 DBMET00515 0.504 0.073 DBMET00524 0.249 0.215 DBMET00529 0.263 0.201 DBMET00527 0.488 0.078 DBMET00517 | DBMET00524 | |
| 0.104 | 0.078 | 0.104 | Calcium channel (voltage-sensitive) blocker | |||
| 0.107 | 0.082 | 0.107 | Calcium channel N-type blocker | |||
| 0.052 | 0.027 | 0.052 | Dopamine beta hydroxylase inhibitor | 0.047 0.037 DBMET00515 0.046 0.04 DBMET00516 0.051 0.028 DBMET00520 0.046 0.04 DBMET01717 0.045 0.043 DBMET01718 | ||
| 0.172 | 0.148 | 0.341 | RNA-directed DNA polymerase inhibitor | 0.22 0.074 DBMET00515 0.182 0.129 DBMET00516 0.186 0.123 DBMET00519 0.178 0.136 DBMET00520 0.311 0.029 DBMET00524 0.196 0.106 DBMET00526 0.182 0.129 DBMET01717 0.176 0.14 DBMET01718 0.217 0.078 DBMET00527 0.341 0.025 DBMET00517 | DBMET00517 | |
| 0.074 | 0.05 | 0.084 | Alpha 1b adrenoreceptor antagonist | 0.084 0.043 DBMET00515 | DBMET00515 | |
| 0.057 | 0.033 | 0.07 | Acetylcholine M2 receptor agonist | 0.053 0.039 DBMET00515 0.07 0.019 DBMET00519 0.064 0.025 DBMET00526 0.06 0.028 DBMET00529 | DBMET00519 | |
| 0.086 | 0.062 | 0.1 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.09 0.057 DBMET00519 0.1 0.046 DBMET00520 0.091 0.056 DBMET00526 | DBMET00520 | |
| 0.094 | 0.07 | 0.172 | Nitric-oxide synthase inhibitor | 0.172 0.015 DBMET00520 0.092 0.074 DBMET00526 | DBMET00520 | |
| 0.036 | 0.012 | 0.036 | CDK4/cyclin D3 inhibitor | |||
| 0.061 | 0.039 | 0.085 | Potassium channel (Ca-activated) blocker | 0.085 0.015 DBMET00515 | DBMET00515 | |
| 0.072 | 0.049 | 0.083 | Phospholipase D inhibitor | 0.072 0.048 DBMET00515 0.083 0.03 DBMET00520 0.081 0.032 DBMET00526 | DBMET00520 | |
| 0.057 | 0.035 | 0.084 | Pim-2 kinase inhibitor | 0.084 0.019 DBMET00520 | DBMET00520 | |
| 0.099 | 0.078 | 0.116 | GABA receptor agonist | 0.111 0.066 DBMET00519 0.091 0.088 DBMET00520 0.116 0.06 DBMET00533 | DBMET00533 | |
| 0.037 | 0.016 | 0.037 | Protein kinase (CK2) beta inhibitor | 0.037 0.016 DBMET00520 0.035 0.018 DBMET00526 0.032 0.027 DBMET01718 | ||
| 0.06 | 0.039 | 0.069 | Cyclin A1 inhibitor | 0.056 0.047 DBMET00519 0.069 0.023 DBMET00520 0.059 0.041 DBMET00526 | DBMET00520 | |
| 0.042 | 0.022 | 0.047 | Vascular adhesion protein 1 inhibitor | 0.047 0.018 DBMET00519 0.038 0.028 DBMET00520 0.044 0.02 DBMET00526 | DBMET00519 | |
| 0.073 | 0.054 | 0.085 | Phosphodiesterase VI inhibitor | 0.085 0.033 DBMET00519 0.081 0.04 DBMET00526 | DBMET00519 | |
| 0.098 | 0.079 | 0.149 | Cystathionine beta-synthase inhibitor | 0.12 0.058 DBMET00516 0.123 0.056 DBMET00519 0.116 0.061 DBMET00526 0.12 0.058 DBMET01717 0.105 0.071 DBMET01718 0.149 0.041 DBMET00527 | DBMET00527 | |
| 0.072 | 0.053 | 0.107 | Rho-associated kinase inhibitor | 0.107 0.032 DBMET00520 | DBMET00520 | |
| 0.136 | 0.118 | 0.282 | Tumour necrosis factor antagonist | 0.174 0.072 DBMET00519 0.228 0.039 DBMET00520 0.282 0.022 DBMET00526 0.189 0.06 DBMET00529 | DBMET00526 | |
| 0.053 | 0.036 | 0.053 | Dipeptidyl peptidase inhibitor | 0.052 0.038 DBMET00515 0.051 0.039 DBMET00520 | ||
| 0.031 | 0.014 | 0.031 | HCV NS5A inhibitor | 0.029 0.017 DBMET00515 0.03 0.015 DBMET00520 | ||
| 0.06 | 0.044 | 0.07 | Adrenaline uptake inhibitor | 0.068 0.036 DBMET00515 0.07 0.034 DBMET00520 0.069 0.036 DBMET00533 | DBMET00520 | |
| 0.073 | 0.057 | 0.102 | Alpha 1 adrenoreceptor antagonist | 0.102 0.043 DBMET00515 | DBMET00515 | |
| 0.02 | 0.004 | 0.023 | Cyclin D2 inhibitor | 0.014 0.008 DBMET00515 0.017 0.004 DBMET00516 0.019 0.004 DBMET00519 0.023 0.003 DBMET00520 0.02 0.004 DBMET00526 0.013 0.011 DBMET00533 0.017 0.004 DBMET01717 | DBMET00520 | |
| 0.054 | 0.038 | 0.063 | Lysine-specific demethylase 1A inhibitor | 0.063 0.024 DBMET00520 | DBMET00520 | |
| 0.068 | 0.053 | 0.128 | Benzodiazepine agonist | 0.082 0.037 DBMET00519 0.065 0.059 DBMET00520 0.128 0.013 DBMET00529 | DBMET00529 | |
| 0.067 | 0.052 | 0.091 | Alpha 1a adrenoreceptor antagonist | 0.091 0.04 DBMET00515 | DBMET00515 | |
| 0.044 | 0.029 | 0.067 | Glutamate (mGluR group III) antagonist | 0.045 0.028 DBMET00516 0.067 0.01 DBMET00519 0.04 0.038 DBMET00520 0.055 0.016 DBMET00526 0.045 0.028 DBMET01717 0.042 0.035 DBMET00529 | DBMET00519 | |
| 0.055 | 0.041 | 0.071 | Bruton tyrosine kinase inhibitor | 0.071 0.025 DBMET00515 | DBMET00515 | |
| 0.087 | 0.075 | 0.087 | Phosphodiesterase 7B inhibitor | 0.084 0.081 DBMET00519 0.085 0.078 DBMET00520 | ||
| 0.056 | 0.044 | 0.056 | Calcium channel T-type blocker | |||
| 0.053 | 0.041 | 0.057 | Sphingosine kinase 2 inhibitor | 0.057 0.036 DBMET00520 | DBMET00520 | |
| 0.109 | 0.098 | 0.204 | DNA repair enzyme inhibitor | 0.114 0.085 DBMET00520 0.204 0.008 DBMET00524 0.107 0.104 DBMET00526 0.115 0.082 DBMET00613 0.12 0.071 DBMET00527 0.189 0.011 DBMET00517 | DBMET00524 | |
| 0.03 | 0.019 | 0.035 | MAP3K8 inhibitor | 0.035 0.011 DBMET00520 | DBMET00520 | |
| 0.081 | 0.07 | 0.112 | Antiadrenergic | 0.088 0.064 DBMET00515 0.112 0.049 DBMET00643 | DBMET00643 | |
| 0.027 | 0.016 | 0.028 | Calcitonin gene-related peptide antagonist | 0.028 0.016 DBMET00515 | DBMET00515 | |
| 0.109 | 0.099 | 0.155 | Sodium channel (voltage-gated) blocker | 0.155 0.051 DBMET00520 0.135 0.067 DBMET00526 0.108 0.1 DBMET00533 | DBMET00520 | |
| 0.044 | 0.034 | 0.044 | 5 Hydroxytryptamine 1A agonist | |||
| 0.074 | 0.065 | 0.088 | MAP kinase kinase 7 inhibitor | 0.088 0.029 DBMET00520 0.076 0.058 DBMET01718 | DBMET00520 | |
| 0.031 | 0.022 | 0.063 | CXC chemokine 3 receptor antagonist | 0.031 0.022 DBMET00515 0.063 0.007 DBMET00519 0.037 0.016 DBMET00529 | DBMET00519 | |
| 0.028 | 0.018 | 0.028 | Sigma 1 receptor antagonist | 0.024 0.02 DBMET00515 | ||
| 0.034 | 0.025 | 0.034 | Opioid delta receptor agonist | 0.032 0.03 DBMET00515 | ||
| 0.038 | 0.029 | 0.038 | Cyclin D3 inhibitor | 0.034 0.032 DBMET00520 | ||
| 0.033 | 0.025 | 0.035 | CDK6/cyclin D3 inhibitor | 0.032 0.026 DBMET00519 0.035 0.022 DBMET00520 0.033 0.024 DBMET00526 | DBMET00520 | |
| 0.165 | 0.158 | 0.277 | Cardiotonic | 0.277 0.067 DBMET00527 | DBMET00527 | |
| 0.044 | 0.037 | 0.057 | Glycine transporter inhibitor | 0.057 0.026 DBMET00515 0.043 0.037 DBMET00520 | DBMET00515 | |
| 0.065 | 0.058 | 0.112 | CXC chemokine receptor antagonist | 0.086 0.033 DBMET00519 0.08 0.037 DBMET00526 0.112 0.019 DBMET00529 | DBMET00529 | |
| 0.023 | 0.017 | 0.023 | Dopamine autoreceptor agonist | |||
| 0.05 | 0.044 | 0.082 | Protein kinase C eta inhibitor | 0.082 0.023 DBMET00515 0.051 0.042 DBMET00524 0.079 0.024 DBMET01718 0.051 0.042 DBMET00527 | DBMET00515 | |
| 0.016 | 0.01 | 0.017 | CXC chemokine 4 receptor agonist | 0.014 0.012 DBMET00519 0.017 0.008 DBMET00520 0.014 0.013 DBMET00526 | DBMET00520 | |
| 0.087 | 0.082 | 0.093 | Insulin receptor antagonist | 0.093 0.072 DBMET00519 | DBMET00519 | |
| 0.037 | 0.031 | 0.042 | MAP3K5 inhibitor | 0.036 0.032 DBMET00519 0.042 0.022 DBMET00520 0.038 0.029 DBMET00526 | DBMET00520 | |
| 0.037 | 0.032 | 0.045 | Protein kinase (CK1) epsilon inhibitor | 0.045 0.018 DBMET00520 | DBMET00520 | |
| 0.075 | 0.071 | 0.174 | Inducible nitric-oxide synthase inhibitor | 0.174 0.012 DBMET00520 0.078 0.065 DBMET00526 | DBMET00520 | |
| 0.025 | 0.021 | 0.031 | Acid ceramidase inhibitor | 0.031 0.008 DBMET00515 | DBMET00515 | |
| 0.071 | 0.067 | 0.108 | Leucine-rich repeat kinase 2 inhibitor | 0.087 0.052 DBMET00520 0.108 0.038 DBMET00526 | DBMET00526 | |
| 0.046 | 0.043 | 0.046 | Prolyl endopeptidase inhibitor | |||
| 0.017 | 0.014 | 0.018 | Histamine H4 receptor agonist | 0.018 0.013 DBMET00520 | DBMET00520 | |
| 0.075 | 0.072 | 0.11 | Adrenaline antagonist | 0.082 0.066 DBMET00515 0.11 0.048 DBMET00643 | DBMET00643 | |
| 0.039 | 0.037 | 0.058 | GABA B receptor antagonist | 0.039 0.037 DBMET00515 0.058 0.013 DBMET00520 | DBMET00520 | |
| 0.051 | 0.048 | 0.064 | Alpha 1d adrenoreceptor antagonist | 0.064 0.038 DBMET00515 | DBMET00515 | |
| 0.055 | 0.052 | 0.058 | Cyclin A2 inhibitor | 0.058 0.048 DBMET00520 | DBMET00520 | |
| 0.041 | 0.039 | 0.041 | Dipeptidyl peptidase IV inhibitor | |||
| 0.243 | 0.242 | 0.285 | MAP kinase 1 inhibitor | 0.276 0.206 DBMET00519 0.253 0.229 DBMET00520 0.285 0.198 DBMET00526 | DBMET00526 | |
| 0.016 | 0.014 | 0.016 | Calcitonin gene-related peptide 1 receptor antagonist | 0.016 0.013 DBMET00515 0.016 0.014 DBMET00526 | ||
| 0.054 | 0.052 | 0.124 | Glutamate (mGluR) agonist | 0.124 0.018 DBMET00519 | DBMET00519 | |
| 0.046 | 0.046 | 0.087 | Protein kinase C epsilon inhibitor | 0.087 0.016 DBMET00520 0.047 0.044 DBMET00526 | DBMET00520 | |
| 0.027 | 0.027 | 0.029 | Dipeptidyl peptidase I inhibitor | 0.029 0.023 DBMET00515 0.028 0.025 DBMET00519 | DBMET00515 | |
| 0.035 | 0.035 | 0.06 | Histone deacetylase 9 inhibitor | 0.042 0.023 DBMET00519 0.048 0.017 DBMET00526 0.06 0.012 DBMET00529 | DBMET00529 | |
| 0.032 | 0.033 | 0.033 | Adenosine uptake inhibitor | 0.033 0.03 DBMET00519 | DBMET00519 | |
| 0.039 | 0.04 | 0.054 | Glutamate (mGluR4) antagonist | 0.041 0.034 DBMET00519 0.052 0.019 DBMET00520 0.054 0.017 DBMET00526 | DBMET00526 | |
| 0.063 | 0.064 | 0.068 | Aminopeptidase I inhibitor | 0.068 0.057 DBMET00520 | DBMET00520 | |
| 0.042 | 0.043 | 0.049 | Aldosterone antagonist | 0.049 0.03 DBMET00520 0.047 0.034 DBMET00526 | DBMET00520 | |
| 0.145 | 0.146 | 0.152 | Neurotrophic factor enhancer | 0.152 0.135 DBMET01718 | DBMET01718 | |
| 0.037 | 0.039 | 0.059 | Guanylate cyclase inhibitor | 0.059 0.013 DBMET00524 0.042 0.03 DBMET00517 | DBMET00524 | |
| 0.029 | 0.032 | 0.045 | ATR kinase inhibitor | 0.045 0.009 DBMET00520 0.031 0.026 DBMET00526 | DBMET00520 | |
| 0.035 | 0.037 | 0.061 | Glutamate (mGluR1a) antagonist | 0.037 0.033 DBMET00519 0.061 0.014 DBMET00520 0.042 0.027 DBMET00526 | DBMET00520 | |
| 0.024 | 0.027 | 0.027 | Myristoyl transferase inhibitor | 0.027 0.02 DBMET00520 | DBMET00520 | |
| 0.123 | 0.126 | 0.134 | MAP kinase 3 inhibitor | 0.134 0.097 DBMET00520 0.13 0.106 DBMET00526 | DBMET00520 | |
| 0.052 | 0.055 | 0.06 | Pregnane X receptor antagonist | 0.053 0.051 DBMET00519 0.055 0.044 DBMET00520 0.058 0.036 DBMET00526 0.06 0.032 DBMET00529 | DBMET00529 | |
| 0.049 | 0.053 | 0.131 | CXC chemokine 4 receptor antagonist | 0.131 0.019 DBMET00520 0.065 0.039 DBMET00526 | DBMET00520 | |
| 0.021 | 0.025 | 0.023 | Phosphodiesterase 9A inhibitor | 0.023 0.019 DBMET00520 0.023 0.02 DBMET00526 | DBMET00526 | |
| 0.051 | 0.055 | 0.06 | 5 Hydroxytryptamine uptake inhibitor | 0.059 0.048 DBMET00515 0.06 0.046 DBMET00520 | DBMET00520 | |
| 0.116 | 0.122 | 0.123 | Hemostatic | 0.123 0.109 DBMET00526 | DBMET00526 | |
| 0.138 | 0.144 | 0.16 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.16 0.115 DBMET00515 | DBMET00515 | |
| 0.08 | 0.087 | 0.094 | Sphingomyelinase inhibitor | 0.094 0.067 DBMET00643 | DBMET00643 | |
| 0.12 | 0.128 | 0.144 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.144 0.1 DBMET00520 | DBMET00520 | |
| 0.004 | 0.012 | 0.006 | CC chemokine 6 receptor agonist | 0.006 0.005 DBMET00520 | DBMET00520 | |
| 0.081 | 0.089 | 0.133 | Lanosterol 14 alpha demethylase inhibitor | 0.116 0.035 DBMET00520 0.118 0.033 DBMET00526 0.133 0.02 DBMET00643 | DBMET00643 | |
| 0.03 | 0.039 | 0.041 | Protein kinase C beta I inhibitor | 0.041 0.008 DBMET00515 0.036 0.016 DBMET00524 0.034 0.02 DBMET00517 | DBMET00515 | |
| 0.139 | 0.149 | 0.201 | Focal adhesion kinase 2 inhibitor | 0.157 0.12 DBMET00519 0.191 0.076 DBMET00520 0.201 0.069 DBMET00526 | DBMET00526 | |
| 0.033 | 0.044 | 0.054 | Neurokinin 1 antagonist | 0.037 0.035 DBMET00515 0.054 0.017 DBMET00520 | DBMET00520 | |
| 0.032 | 0.043 | 0.093 | Dopamine D5 agonist | 0.036 0.034 DBMET00515 0.093 0.005 DBMET00520 0.037 0.032 DBMET00526 | DBMET00520 | |
| 0.031 | 0.042 | 0.06 | Substance P antagonist | 0.06 0.012 DBMET00520 | DBMET00520 | |
| 0.015 | 0.027 | 0.025 | Imidazoline I1 receptor antagonist | 0.025 0.01 DBMET00520 | DBMET00520 | |
| 0.015 | 0.027 | 0.023 | Alpha 2b adrenoreceptor agonist | 0.023 0.007 DBMET00520 | DBMET00520 | |
| 0.012 | 0.025 | 0.021 | Cyclin T1 inhibitor | 0.021 0.009 DBMET00520 | DBMET00520 | |
| 0.023 | 0.037 | 0.032 | Glucosylceramidase stimulant | 0.029 0.014 DBMET00519 0.026 0.025 DBMET00520 0.032 0.009 DBMET00526 | DBMET00526 | |
| 0.014 | 0.028 | 0.019 | Complement factor D inhibitor | 0.019 0.011 DBMET00520 | DBMET00520 | |
| 0.077 | 0.091 | 0.093 | MAP kinase kinase kinase inhibitor | 0.093 0.073 DBMET00520 | DBMET00520 | |
| 0.023 | 0.037 | 0.026 | Hedgehog signaling activator | 0.026 0.024 DBMET00527 | DBMET00527 | |
| 0.035 | 0.049 | 0.057 | Geranyltranstransferase inhibitor | 0.043 0.031 DBMET00515 0.057 0.016 DBMET00520 | DBMET00520 | |
| 0.009 | 0.024 | 0.018 | Somatostatin 2 agonist | 0.018 0.007 DBMET00520 | DBMET00520 | |
| 0.046 | 0.061 | 0.072 | Protein kinase C theta inhibitor | 0.072 0.021 DBMET00520 | DBMET00520 | |
| 0.087 | 0.102 | 0.154 | GABA C receptor antagonist | 0.154 0.028 DBMET00520 0.109 0.065 DBMET00526 | DBMET00520 | |
| 0.039 | 0.055 | 0.143 | Dopamine D4 agonist | 0.143 0.01 DBMET00529 | DBMET00529 | |
| 0.007 | 0.024 | 0.01 | Imidazoline I2 receptor antagonist | 0.01 0.009 DBMET00520 | DBMET00520 | |
| 0.044 | 0.061 | 0.102 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.052 0.044 DBMET00516 0.05 0.049 DBMET00519 0.056 0.04 DBMET00520 0.089 0.017 DBMET00524 0.063 0.032 DBMET00526 0.052 0.044 DBMET01717 0.053 0.044 DBMET01718 0.077 0.022 DBMET00527 0.102 0.014 DBMET00517 | DBMET00517 | |
| 0.078 | 0.096 | 0.124 | Interleukin 1 beta converting enzyme inhibitor | 0.124 0.032 DBMET00515 0.095 0.064 DBMET00519 | DBMET00515 | |
| 0.089 | 0.108 | 0.096 | CDC-like kinase 3 inhibitor | 0.096 0.088 DBMET00519 | DBMET00519 | |
| 0.057 | 0.077 | 0.112 | Rho-associated kinase I inhibitor | 0.112 0.024 DBMET00520 | DBMET00520 | |
| 0.033 | 0.053 | 0.049 | Plasmepsin II inhibitor | 0.047 0.02 DBMET00520 0.049 0.019 DBMET00526 | DBMET00526 | |
| 0.015 | 0.035 | 0.02 | Glutamate (mGluR1a) agonist | 0.02 0.018 DBMET00520 | DBMET00520 | |
| 0.008 | 0.028 | 0.02 | Human herpes virus 5 capsid protein P40 inhibitor | 0.02 0.004 DBMET00529 | DBMET00529 | |
| 0.02 | 0.041 | 0.033 | Endothelial nitric-oxide synthase inhibitor | 0.033 0.02 DBMET00520 | DBMET00520 | |
| 0.029 | 0.05 | 0.034 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.03 DBMET00520 | DBMET00520 | |
| 0.074 | 0.095 | 0.128 | Hematopoietic | 0.086 0.057 DBMET00519 0.128 0.019 DBMET00526 | DBMET00526 | |
| 0.01 | 0.031 | 0.018 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.018 0.015 DBMET00520 | DBMET00520 | |
| 0.012 | 0.034 | 0.022 | Alpha 2c adrenoreceptor agonist | 0.022 0.009 DBMET00520 | DBMET00520 | |
| 0.13 | 0.152 | 0.144 | EphB2 antagonist | 0.144 0.136 DBMET00520 | DBMET00520 | |
| 0.039 | 0.064 | 0.05 | Aconitate hydratase inhibitor | 0.048 0.043 DBMET00516 0.047 0.044 DBMET00520 0.05 0.039 DBMET00526 0.048 0.043 DBMET01717 | DBMET00526 | |
| 0.125 | 0.15 | 0.135 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.135 0.13 DBMET00515 | DBMET00515 | |
| 0.038 | 0.064 | 0.085 | Benzodiazepine inverse agonist | 0.085 0.005 DBMET00529 | DBMET00529 | |
| 0.027 | 0.054 | 0.044 | Oxytocin agonist | 0.044 0.028 DBMET00526 | DBMET00526 | |
| 0.075 | 0.102 | 0.083 | MAP kinase kinase 1 inhibitor | 0.083 0.082 DBMET00519 | DBMET00519 | |
| 0.05 | 0.077 | 0.135 | Cyclin B3 inhibitor | 0.135 0.017 DBMET00526 | DBMET00526 | |
| 0.059 | 0.086 | 0.078 | MDM2 inhibitor | 0.069 0.04 DBMET00519 0.067 0.046 DBMET00520 0.078 0.023 DBMET00526 0.068 0.044 DBMET00527 | DBMET00526 | |
| 0.04 | 0.068 | 0.117 | Bromodomain-containing protein 4 inhibitor | 0.117 0.01 DBMET00515 0.068 0.026 DBMET00519 | DBMET00515 | |
| 0.034 | 0.062 | 0.047 | Bromodomain-containing protein 3 inhibitor | 0.047 0.039 DBMET00515 | DBMET00515 | |
| 0.05 | 0.079 | 0.057 | Ryanodine receptor antagonist | 0.057 0.047 DBMET00515 | DBMET00515 | |
| 0.168 | 0.197 | 0.255 | Cholesterol antagonist | 0.243 0.13 DBMET00524 0.255 0.122 DBMET00643 0.226 0.143 DBMET00527 0.2 0.164 DBMET00517 | DBMET00643 | |
| 0.038 | 0.067 | 0.048 | Topoisomerase II beta inhibitor | 0.048 0.036 DBMET00520 | DBMET00520 | |
| 0.186 | 0.215 | 0.367 | Interleukin 2 agonist | 0.238 0.133 DBMET00515 0.279 0.09 DBMET00519 0.296 0.076 DBMET00524 0.367 0.039 DBMET00526 0.27 0.098 DBMET00529 0.243 0.127 DBMET00527 0.338 0.051 DBMET00517 | DBMET00526 | |
| 0.052 | 0.081 | 0.101 | Porphobilinogen synthase inhibitor | 0.082 0.046 DBMET00520 0.101 0.035 DBMET00526 0.064 0.063 DBMET00613 0.069 0.057 DBMET01718 | DBMET00526 | |
| 0.058 | 0.088 | 0.066 | Glycine receptor agonist | 0.066 0.063 DBMET00527 | DBMET00527 | |
| 0.025 | 0.055 | 0.042 | Protein kinase C beta II inhibitor | 0.042 0.009 DBMET00515 | DBMET00515 | |
| 0.042 | 0.074 | 0.087 | Protein kinase C iota inhibitor | 0.087 0.023 DBMET00520 | DBMET00520 | |
| 0.055 | 0.087 | 0.088 | Secretase beta inhibitor | 0.074 0.043 DBMET00519 0.069 0.051 DBMET00520 0.088 0.027 DBMET00526 | DBMET00526 | |
| 0.049 | 0.081 | 0.078 | Nav1.7 sodium channel blocker | 0.078 0.035 DBMET00520 0.068 0.047 DBMET00526 | DBMET00520 | |
| 0.061 | 0.094 | 0.08 | CDK/cyclin complex inhibitor | 0.08 0.069 DBMET00520 | DBMET00520 | |
| 0.051 | 0.085 | 0.086 | Protein kinase C alpha inhibitor | 0.076 0.037 DBMET00515 0.086 0.03 DBMET00520 0.061 0.059 DBMET01718 | DBMET00520 | |
| 0.081 | 0.115 | 0.118 | MAP kinase 13 inhibitor | 0.118 0.058 DBMET00520 0.102 0.078 DBMET00526 | DBMET00520 | |
| 0.075 | 0.109 | 0.124 | Protein kinase (CK2) alpha inhibitor | 0.124 0.06 DBMET00520 0.11 0.069 DBMET00526 | DBMET00520 | |
| 0.04 | 0.076 | 0.052 | Bombesin 3 receptor antagonist | 0.052 0.043 DBMET00520 | DBMET00520 | |
| 0.106 | 0.143 | 0.121 | Heat shock protein 90 antagonist | 0.121 0.112 DBMET00526 | DBMET00526 | |
| 0.041 | 0.078 | 0.075 | Glucosylceramidase inhibitor | 0.063 0.028 DBMET00520 0.075 0.019 DBMET01718 0.066 0.025 DBMET00527 | DBMET01718 | |
| 0.033 | 0.071 | 0.053 | Neurokinin antagonist | 0.053 0.03 DBMET00520 | DBMET00520 | |
| 0.172 | 0.21 | 0.456 | Vasodilator, coronary | 0.456 0.022 DBMET00524 0.272 0.113 DBMET00613 0.273 0.111 DBMET00643 0.207 0.176 DBMET00527 0.421 0.029 DBMET00517 | DBMET00524 | |
| 0.022 | 0.06 | 0.075 | 5 Hydroxytryptamine 2C agonist | 0.075 0.012 DBMET00520 0.049 0.029 DBMET00526 | DBMET00520 | |
| 0.035 | 0.074 | 0.058 | GABA receptor antagonist | 0.058 0.034 DBMET00520 | DBMET00520 | |
| 0.021 | 0.06 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.018 DBMET00524 0.026 0.02 DBMET00526 0.027 0.017 DBMET00527 0.026 0.019 DBMET00517 | DBMET00527 | |
| 0.033 | 0.072 | 0.049 | Transforming growth factor beta 1 antagonist | 0.049 0.035 DBMET00520 | DBMET00520 | |
| 0.025 | 0.065 | 0.059 | CDK5/p25 inhibitor | 0.045 0.025 DBMET00520 0.059 0.016 DBMET00526 | DBMET00526 | |
| 0.024 | 0.064 | 0.037 | p53 inhibitor | 0.033 0.028 DBMET00519 0.037 0.023 DBMET00526 | DBMET00526 | |
| 0.024 | 0.065 | 0.054 | DNA gyrase subunit B inhibitor | 0.054 0.011 DBMET00520 0.039 0.024 DBMET00526 | DBMET00520 | |
| 0.081 | 0.122 | 0.335 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.335 0.012 DBMET00533 | DBMET00533 | |
| 0.117 | 0.158 | 0.424 | DNA methylase inhibitor | 0.151 0.117 DBMET00515 0.424 0.009 DBMET00524 0.344 0.018 DBMET00517 | DBMET00524 | |
| 0.037 | 0.08 | 0.056 | Alpha-mannosidase inhibitor | 0.056 0.033 DBMET00520 0.056 0.032 DBMET01718 0.055 0.035 DBMET00527 | DBMET01718 | |
| 0.08 | 0.123 | 0.133 | Beta amyloid protein antagonist | 0.133 0.054 DBMET00520 | DBMET00520 | |
| 0.014 | 0.058 | 0.019 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.019 0.018 DBMET00526 | DBMET00526 | |
| 0.064 | 0.108 | 0.105 | Protein kinase (CK2) inhibitor | 0.105 0.06 DBMET00520 0.103 0.061 DBMET00526 | DBMET00520 | |
| 0.088 | 0.134 | 0.126 | Sodium channel blocker | 0.126 0.078 DBMET00520 | DBMET00520 | |
| 0.063 | 0.11 | 0.37 | Bronchodilator | 0.089 0.076 DBMET00519 0.287 0.01 DBMET00533 0.254 0.013 DBMET00643 0.37 0.006 DBMET00529 0.094 0.071 DBMET00527 | DBMET00529 | |
| 0.021 | 0.068 | 0.034 | Histone deacetylase 7 inhibitor | 0.034 0.029 DBMET00526 | DBMET00526 | |
| 0.111 | 0.16 | 0.13 | Interferon gamma antagonist | 0.128 0.115 DBMET00520 0.13 0.111 DBMET00526 | DBMET00526 | |
| 0.067 | 0.117 | 0.16 | Cyclin-dependent kinase 5 inhibitor | 0.14 0.046 DBMET00520 0.16 0.035 DBMET00526 | DBMET00526 | |
| 0.076 | 0.126 | 0.315 | Alkylator | 0.106 0.082 DBMET00515 0.182 0.032 DBMET00524 0.315 0.012 DBMET00613 0.233 0.019 DBMET00643 0.19 0.029 DBMET00517 | DBMET00613 | |
| 0.084 | 0.135 | 0.47 | Phosphodiesterase inhibitor | 0.117 0.085 DBMET00533 0.47 0.005 DBMET00529 | DBMET00529 | |
| 0.012 | 0.063 | 0.042 | Poly(ADP-ribose) polymerase 2 inhibitor | 0.042 0.011 DBMET00520 | DBMET00520 | |
| 0.019 | 0.07 | 0.061 | Diamine oxidase inhibitor | 0.038 0.026 DBMET00613 0.061 0.009 DBMET00643 | DBMET00643 | |
| 0.049 | 0.103 | 0.068 | Histone deacetylase SIRT3 inhibitor | 0.062 0.043 DBMET00520 0.068 0.031 DBMET00526 | DBMET00526 | |
| 0.038 | 0.094 | 0.092 | NMDA 2 receptor antagonist | 0.077 0.046 DBMET00515 0.092 0.037 DBMET00520 | DBMET00520 | |
| 0.083 | 0.139 | 0.151 | Cytokine production inhibitor | 0.145 0.066 DBMET00519 0.151 0.062 DBMET00526 | DBMET00526 | |
| 0.038 | 0.094 | 0.053 | Thromboxane synthase inhibitor | 0.053 0.042 DBMET00526 | DBMET00526 | |
| 0.035 | 0.091 | 0.073 | NMDA 2C receptor antagonist | 0.073 0.031 DBMET00520 | DBMET00520 | |
| 0.061 | 0.117 | 0.13 | Pim-1 kinase inhibitor | 0.13 0.036 DBMET00520 | DBMET00520 | |
| 0.041 | 0.098 | 0.069 | Phenylalanine 4-hydroxylase inhibitor | 0.069 0.047 DBMET00520 0.069 0.047 DBMET00526 0.061 0.057 DBMET00643 | DBMET00526 | |
| 0.008 | 0.066 | 0.025 | Adenosine kinase inhibitor | 0.025 0.013 DBMET00524 | DBMET00524 | |
| 0.077 | 0.134 | 0.122 | MAP kinase 12 inhibitor | 0.122 0.068 DBMET00520 0.108 0.087 DBMET00526 | DBMET00520 | |
| 0.067 | 0.125 | 0.092 | Granulocyte macrophage colony stimulating factor agonist | 0.088 0.056 DBMET00520 0.092 0.047 DBMET00526 | DBMET00526 | |
| 0.006 | 0.065 | 0.022 | 5-Alpha-reductase 1 inhibitor | 0.022 0.01 DBMET00519 | DBMET00519 | |
| 0.029 | 0.088 | 0.057 | Glutamate (mGluR1) antagonist | 0.057 0.042 DBMET00526 | DBMET00526 | |
| 0.02 | 0.081 | 0.054 | Factor XIIIa inhibitor | 0.054 0.014 DBMET00613 | DBMET00613 | |
| 0.107 | 0.168 | 0.163 | Sphingosine 1-phosphate receptor 5 antagonist | 0.163 0.042 DBMET00520 | DBMET00520 | |
| 0.111 | 0.172 | 0.141 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.141 0.091 DBMET00526 0.127 0.123 DBMET01718 | DBMET00526 | |
| 0.118 | 0.18 | 0.154 | Death-associated protein kinase 3 inhibitor | 0.154 0.116 DBMET00520 | DBMET00520 | |
| 0.129 | 0.191 | 0.202 | Histone acetyltransferase inhibitor | 0.193 0.079 DBMET00519 0.202 0.066 DBMET00526 | DBMET00526 | |
| 0.08 | 0.145 | 0.129 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.129 0.078 DBMET00515 | DBMET00515 | |
| 0.026 | 0.091 | 0.051 | Thymidine kinase inhibitor | 0.051 0.018 DBMET00524 0.041 0.028 DBMET00527 0.051 0.018 DBMET00517 | DBMET00517 | |
| 0.032 | 0.098 | 0.076 | Myc inhibitor | 0.076 0.015 DBMET00520 | DBMET00520 | |
| 0.029 | 0.096 | 0.063 | Alcohol oxidase inhibitor | 0.059 0.036 DBMET00526 0.063 0.033 DBMET00527 | DBMET00527 | |
| 0.052 | 0.119 | 0.074 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.074 0.049 DBMET00520 | DBMET00520 | |
| 0.02 | 0.087 | 0.046 | Poly(ADP-ribose) polymerase 1 inhibitor | 0.046 0.019 DBMET00520 | DBMET00520 | |
| 0.015 | 0.082 | 0.027 | Somatostatin agonist | 0.027 0.026 DBMET00520 | DBMET00520 | |
| 0.077 | 0.145 | 0.156 | Ribosomal protein S6 kinase inhibitor | 0.156 0.06 DBMET00520 | DBMET00520 | |
| 0.009 | 0.077 | 0.043 | Glycine transporter 1 inhibitor | 0.043 0.019 DBMET00520 | DBMET00520 | |
| 0.016 | 0.084 | 0.038 | Purinergic P2X7 antagonist | 0.038 0.023 DBMET00519 | DBMET00519 | |
| 0.05 | 0.119 | 0.096 | Adrenaline agonist | 0.076 0.063 DBMET00520 0.096 0.04 DBMET00643 | DBMET00643 | |
| 0.062 | 0.132 | 0.109 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.109 0.079 DBMET00533 | DBMET00533 | |
| 0.04 | 0.11 | 0.093 | DNA gyrase inhibitor | 0.093 0.02 DBMET00520 0.084 0.024 DBMET00526 | DBMET00520 | |
| 0.026 | 0.097 | 0.06 | Poly(ADP-ribose) polymerase inhibitor | 0.06 0.017 DBMET00520 | DBMET00520 | |
| 0.061 | 0.132 | 0.108 | Abl kinase inhibitor | 0.108 0.079 DBMET00533 | DBMET00533 | |
| 0.024 | 0.095 | 0.077 | Aromatase inhibitor | 0.059 0.042 DBMET00520 0.077 0.029 DBMET00526 | DBMET00526 | |
| 0.085 | 0.156 | 0.185 | Peroxidase inhibitor | 0.154 0.076 DBMET00520 0.185 0.063 DBMET00526 | DBMET00526 | |
| 0.023 | 0.095 | 0.042 | Mannosidase inhibitor | 0.042 0.036 DBMET00520 0.041 0.038 DBMET01718 0.041 0.039 DBMET00527 | DBMET00520 | |
| 0.113 | 0.186 | 0.172 | 3C-like protease (Human coronavirus) inhibitor | 0.172 0.072 DBMET00520 0.148 0.105 DBMET00526 | DBMET00520 | |
| 0.033 | 0.109 | 0.07 | Carbonic anhydrase stimulant | 0.07 0.031 DBMET00520 | DBMET00520 | |
| 0.038 | 0.114 | 0.055 | Sphingosine kinase inhibitor | 0.055 0.049 DBMET00520 | DBMET00520 | |
| 0.062 | 0.139 | 0.098 | Ferrochelatase inhibitor | 0.09 0.083 DBMET00519 0.098 0.073 DBMET00526 | DBMET00526 | |
| 0.028 | 0.106 | 0.071 | DNA gyrase subunit A inhibitor | 0.064 0.009 DBMET00520 0.071 0.007 DBMET00526 | DBMET00526 | |
| 0.075 | 0.153 | 0.211 | Acetylcholinesterase inhibitor | 0.211 0.03 DBMET00515 0.173 0.043 DBMET00533 | DBMET00515 | |
| 0.135 | 0.214 | 0.169 | MAP-kinase-activated kinase 5 inhibitor | 0.165 0.156 DBMET00519 0.169 0.15 DBMET00520 | DBMET00520 | |
| 0.009 | 0.092 | 0.017 | 5-Alpha-reductase 2 inhibitor | 0.017 0.016 DBMET00519 | DBMET00519 | |
| 0.039 | 0.122 | 0.078 | I kappa B kinase 2 inhibitor | 0.078 0.024 DBMET00520 | DBMET00520 | |
| 0.047 | 0.135 | 0.089 | NMDA receptor antagonist | 0.089 0.055 DBMET00520 | DBMET00520 | |
| 0.045 | 0.134 | 0.105 | Kallikrein 7 inhibitor | 0.065 0.04 DBMET00526 0.105 0.004 DBMET00613 0.089 0.008 DBMET00643 | DBMET00613 | |
| 0.012 | 0.101 | 0.049 | 5-Alpha-reductase inhibitor | 0.049 0.019 DBMET00519 0.033 0.03 DBMET00527 | DBMET00519 | |
| 0.118 | 0.208 | 0.146 | Cyclin-dependent kinase 3 inhibitor | 0.146 0.106 DBMET01718 | DBMET01718 | |
| 0.03 | 0.121 | 0.065 | Androgen agonist | 0.065 0.035 DBMET00527 | DBMET00527 | |
| 0.053 | 0.144 | 0.117 | Chemokine receptor antagonist | 0.117 0.049 DBMET00529 | DBMET00529 | |
| 0.027 | 0.119 | 0.074 | Farnesyltransferase inhibitor | 0.074 0.014 DBMET00529 | DBMET00529 | |
| 0.028 | 0.122 | 0.094 | Carbamoyl phosphate synthetase inhibitor | 0.088 0.025 DBMET00524 0.094 0.022 DBMET00517 | DBMET00517 | |
| 0.04 | 0.136 | 0.157 | Histone deacetylase SIRT1 stimulant | 0.157 0.008 DBMET00524 0.15 0.009 DBMET00517 | DBMET00524 | |
| 0.04 | 0.136 | 0.157 | Histone deacetylase stimulant | 0.157 0.008 DBMET00524 0.15 0.009 DBMET00517 | DBMET00524 | |
| 0.145 | 0.243 | 0.432 | Immunomodulator | 0.209 0.153 DBMET00519 0.216 0.146 DBMET00520 0.385 0.049 DBMET00524 0.314 0.075 DBMET00526 0.194 0.172 DBMET00529 0.432 0.036 DBMET00517 | DBMET00517 | |
| 0.054 | 0.152 | 0.164 | Expectorant | 0.164 0.03 DBMET00524 0.115 0.055 DBMET00517 | DBMET00524 | |
| 0.041 | 0.139 | 0.143 | MAP-kinase-activated kinase 2 inhibitor | 0.143 0.013 DBMET00520 0.097 0.03 DBMET00526 | DBMET00520 | |
| 0.044 | 0.146 | 0.1 | I kappa B kinase inhibitor | 0.1 0.039 DBMET00520 | DBMET00520 | |
| 0.012 | 0.115 | 0.108 | Vasopressin 2 antagonist | 0.108 0.005 DBMET00516 0.108 0.005 DBMET01717 | DBMET01717 | |
| 0.028 | 0.131 | 0.061 | NMDA 2B receptor antagonist | 0.061 0.03 DBMET00515 | DBMET00515 | |
| 0.042 | 0.147 | 0.115 | Somatostatin 1 agonist | 0.115 0.026 DBMET00526 | DBMET00526 | |
| 0.094 | 0.2 | 0.137 | Adenylate cyclase stimulant | 0.137 0.086 DBMET00520 0.123 0.117 DBMET00524 | DBMET00520 | |
| 0.005 | 0.111 | 0.011 | Purinergic P2Y2 agonist | 0.01 0.008 DBMET00524 0.011 0.006 DBMET00517 | DBMET00517 | |
| 0.046 | 0.153 | 0.153 | MAP-kinase-activated kinase inhibitor | 0.153 0.014 DBMET00520 0.108 0.033 DBMET00526 | DBMET00520 | |
| 0.073 | 0.182 | 0.135 | Protein kinase C nu inhibitor | 0.135 0.079 DBMET01718 | DBMET01718 | |
| 0.077 | 0.19 | 0.126 | Protein kinase stimulant | 0.126 0.087 DBMET00524 | DBMET00524 | |
| 0.031 | 0.144 | 0.155 | Phosphodiesterase 4B inhibitor | 0.066 0.048 DBMET00519 0.061 0.055 DBMET00526 0.155 0.012 DBMET00529 | DBMET00529 | |
| 0.053 | 0.167 | 0.109 | Factor XII inhibitor | 0.109 0.03 DBMET00526 | DBMET00526 | |
| 0.023 | 0.138 | 0.224 | Phosphodiesterase 4C inhibitor | 0.224 0.005 DBMET00529 | DBMET00529 | |
| 0.02 | 0.135 | 0.048 | Purinergic P2X antagonist | 0.048 0.034 DBMET00519 | DBMET00519 | |
| 0.122 | 0.238 | 0.321 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.321 0.018 DBMET00524 0.154 0.139 DBMET00529 0.158 0.131 DBMET00527 0.312 0.02 DBMET00517 | DBMET00524 | |
| 0.207 | 0.323 | 0.399 | Antiinflammatory | 0.399 0.14 DBMET00524 0.377 0.153 DBMET00517 | DBMET00524 | |
| 0.089 | 0.205 | 0.344 | DNA methyltransferase I inhibitor | 0.344 0.015 DBMET00524 0.293 0.029 DBMET00517 | DBMET00524 | |
| 0.035 | 0.152 | 0.25 | Phosphodiesterase IV inhibitor | 0.074 0.068 DBMET00519 0.077 0.065 DBMET00526 0.129 0.029 DBMET00533 0.25 0.008 DBMET00529 | DBMET00529 | |
| 0.042 | 0.16 | 0.193 | Butyrylcholinesterase inhibitor | 0.193 0.023 DBMET00515 0.084 0.077 DBMET00533 | DBMET00515 | |
| 0.017 | 0.135 | 0.048 | Adenosine deaminase inhibitor | 0.048 0.032 DBMET00524 | DBMET00524 | |
| 0.062 | 0.185 | 0.102 | Microtubule formation inhibitor | 0.102 0.088 DBMET00526 | DBMET00526 | |
| 0.02 | 0.143 | 0.153 | Raf kinase B inhibitor | 0.153 0.013 DBMET01718 | DBMET01718 | |
| 0.078 | 0.202 | 0.183 | Cell wall synthesis inhibitor | 0.122 0.096 DBMET00515 0.145 0.07 DBMET00520 0.183 0.038 DBMET00526 | DBMET00526 | |
| 0.014 | 0.138 | 0.051 | NMDA 2A receptor antagonist | 0.051 0.037 DBMET00515 | DBMET00515 | |
| 0.061 | 0.185 | 0.174 | Nav1.4 sodium channel blocker | 0.094 0.086 DBMET00520 0.174 0.025 DBMET00526 | DBMET00526 | |
| 0.005 | 0.13 | 0.039 | Vasopressin 1A antagonist | 0.039 0.015 DBMET00516 0.039 0.015 DBMET01717 | DBMET01717 | |
| 0.013 | 0.14 | 0.059 | Purinergic P2Y antagonist | 0.059 0.02 DBMET00524 0.055 0.023 DBMET00517 | DBMET00524 | |
| 0.017 | 0.151 | 0.448 | Phosphodiesterase 4A inhibitor | 0.448 0.004 DBMET00529 | DBMET00529 | |
| 0.08 | 0.217 | 0.135 | Hexokinase inhibitor | 0.135 0.098 DBMET00524 | DBMET00524 | |
| 0.054 | 0.192 | 0.171 | Adenylate cyclase inhibitor | 0.171 0.033 DBMET00524 0.122 0.065 DBMET00517 | DBMET00524 | |
| 0.026 | 0.164 | 0.157 | Raf kinase inhibitor | 0.157 0.018 DBMET01718 | DBMET01718 | |
| 0.025 | 0.164 | 0.066 | Cyclin B1 inhibitor | 0.066 0.037 DBMET00526 | DBMET00526 | |
| 0.083 | 0.224 | 0.195 | Insulin secretagoues | 0.195 0.038 DBMET00520 0.167 0.058 DBMET00524 0.151 0.073 DBMET00526 0.133 0.093 DBMET00529 0.159 0.065 DBMET00517 | DBMET00520 | |
| 0.022 | 0.165 | 0.133 | Biliverdin reductase inhibitor | 0.1 0.018 DBMET00524 0.133 0.012 DBMET00517 | DBMET00517 | |
| 0.02 | 0.167 | 0.04 | GHS receptor agonist | 0.04 0.035 DBMET00520 | DBMET00520 | |
| 0.005 | 0.153 | 0.034 | Vasopressin 1 antagonist | 0.034 0.021 DBMET00516 0.034 0.021 DBMET01717 | DBMET01717 | |
| 0.099 | 0.249 | 0.141 | MAP kinase kinase 4 inhibitor | 0.141 0.082 DBMET00520 | DBMET00520 | |
| 0.046 | 0.198 | 0.294 | UDP-glucose 4-epimerase inhibitor | 0.221 0.016 DBMET00524 0.088 0.076 DBMET00526 0.098 0.063 DBMET00527 0.294 0.01 DBMET00517 | DBMET00517 | |
| 0.019 | 0.172 | 0.08 | Argininosuccinate synthase inhibitor | 0.071 0.03 DBMET00524 0.08 0.025 DBMET00517 | DBMET00517 | |
| 0.006 | 0.162 | 0.021 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.021 0.006 DBMET00524 0.02 0.007 DBMET00517 | DBMET00524 | |
| 0.049 | 0.207 | 0.123 | NADH dehydrogenase inhibitor | 0.113 0.033 DBMET00524 0.123 0.027 DBMET00517 | DBMET00517 | |
| 0.052 | 0.209 | 0.129 | AMP-activated protein kinase stimulant | 0.129 0.042 DBMET00524 | DBMET00524 | |
| 0.036 | 0.194 | 0.122 | Glutamate dehydrogenase inhibitor | 0.109 0.027 DBMET00524 0.122 0.022 DBMET00517 | DBMET00517 | |
| 0.006 | 0.164 | 0.038 | Purinergic P2X agonist | 0.037 0.014 DBMET00524 0.038 0.013 DBMET00517 | DBMET00517 | |
| 0.137 | 0.295 | 0.631 | Antiobesity | 0.631 0.017 DBMET00533 | DBMET00533 | |
| 0.088 | 0.247 | 0.384 | Immunostimulant | 0.384 0.054 DBMET00524 0.192 0.125 DBMET00643 0.339 0.067 DBMET00517 | DBMET00524 | |
| 0.032 | 0.191 | 0.161 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.161 0.025 DBMET01718 | DBMET01718 | |
| 0.009 | 0.171 | 0.037 | Fumarate hydratase inhibitor | 0.031 0.028 DBMET00524 0.037 0.021 DBMET00517 | DBMET00517 | |
| 0.015 | 0.177 | 0.051 | Adenosine A1 receptor antagonist | 0.051 0.048 DBMET00517 | DBMET00517 | |
| 0.02 | 0.184 | 0.135 | Phosphofructokinase-1 inhibitor | 0.127 0.023 DBMET00524 0.135 0.021 DBMET00517 | DBMET00517 | |
| 0.039 | 0.205 | 0.136 | Platelet activating factor antagonist | 0.136 0.053 DBMET00529 | DBMET00529 | |
| 0.007 | 0.175 | 0.104 | Antidiuretic hormone antagonist | 0.104 0.012 DBMET00516 0.104 0.012 DBMET01717 | DBMET01717 | |
| 0.017 | 0.186 | 0.059 | Cyclin B2 inhibitor | 0.059 0.033 DBMET00526 | DBMET00526 | |
| 0.137 | 0.307 | 0.475 | Apoptosis antagonist | 0.475 0.024 DBMET00515 0.291 0.092 DBMET00524 0.197 0.184 DBMET00529 0.279 0.101 DBMET00517 | DBMET00515 | |
| 0.007 | 0.178 | 0.039 | Kinesin-like protein 1 inhibitor | 0.039 0.023 DBMET00533 | DBMET00533 | |
| 0.007 | 0.178 | 0.039 | Kinesin antagonist | 0.039 0.023 DBMET00533 | DBMET00533 | |
| 0.011 | 0.181 | 0.134 | Oxytocin antagonist | 0.134 0.007 DBMET00516 0.038 0.026 DBMET00526 0.134 0.007 DBMET01717 | DBMET01717 | |
| 0.177 | 0.35 | 0.318 | 5 Hydroxytryptamine release inhibitor | 0.273 0.198 DBMET00520 0.318 0.146 DBMET00526 | DBMET00526 | |
| 0.058 | 0.23 | 0.13 | Interleukin 12 antagonist | 0.102 0.051 DBMET00519 0.13 0.021 DBMET00526 | DBMET00526 | |
| 0.058 | 0.235 | 0.117 | Adenylate kinase inhibitor | 0.113 0.05 DBMET00524 0.117 0.046 DBMET00517 | DBMET00517 | |
| 0.028 | 0.205 | 0.055 | Antiviral (Hepatitis D) | 0.054 0.03 DBMET00519 0.055 0.029 DBMET00527 | DBMET00527 | |
| 0.022 | 0.203 | 0.06 | Sphingosine 1-phosphate receptor 3 antagonist | 0.06 0.038 DBMET00520 | DBMET00520 | |
| 0.018 | 0.2 | 0.05 | Cyclin B inhibitor | 0.05 0.045 DBMET00526 | DBMET00526 | |
| 0.028 | 0.214 | 0.065 | Potassium channel (ATP-sensitive) blocker | 0.065 0.05 DBMET00613 | DBMET00613 | |
| 0.036 | 0.223 | 0.085 | Potassium channel activator | 0.085 0.067 DBMET00526 | DBMET00526 | |
| 0.039 | 0.226 | 0.102 | Topoisomerase II inhibitor | 0.102 0.084 DBMET00520 | DBMET00520 | |
| 0.048 | 0.244 | 0.151 | CDC-like kinase 2 inhibitor | 0.151 0.092 DBMET00520 | DBMET00520 | |
| 0.033 | 0.233 | 0.072 | Adenosine A3 receptor antagonist | 0.072 0.055 DBMET00524 0.067 0.063 DBMET00517 | DBMET00524 | |
| 0.125 | 0.325 | 0.684 | Toll-Like receptor 7 agonist | 0.684 0.01 DBMET00529 | DBMET00529 | |
| 0.036 | 0.239 | 0.1 | DNA intercalator | 0.094 0.081 DBMET00515 0.1 0.074 DBMET00613 | DBMET00613 | |
| 0.117 | 0.324 | 0.342 | Peptidyltransferase inhibitor | 0.341 0.014 DBMET00524 0.212 0.085 DBMET00526 0.258 0.045 DBMET00643 0.223 0.073 DBMET00527 0.342 0.014 DBMET00517 | DBMET00517 | |
| 0.076 | 0.284 | 0.199 | Platelet aggregation inhibitor | 0.199 0.081 DBMET00529 0.188 0.091 DBMET00527 | DBMET00529 | |
| 0.024 | 0.233 | 0.121 | Androgen antagonist | 0.093 0.052 DBMET00519 0.092 0.053 DBMET00526 0.121 0.033 DBMET00527 | DBMET00527 | |
| 0.056 | 0.267 | 0.198 | Anticoagulant | 0.198 0.054 DBMET00524 0.195 0.055 DBMET00529 0.178 0.062 DBMET00517 | DBMET00524 | |
| 0.119 | 0.337 | 0.677 | Toll-Like receptor agonist | 0.677 0.01 DBMET00529 | DBMET00529 | |
| 0.063 | 0.285 | 0.116 | Sphingosine 1-phosphate receptor 4 antagonist | 0.116 0.079 DBMET00520 | DBMET00520 | |
| 0.058 | 0.288 | 0.132 | MAP3K9 inhibitor | 0.132 0.091 DBMET01718 | DBMET01718 | |
| 0.076 | 0.317 | 0.143 | Succinate dehydrogenase inhibitor | 0.143 0.125 DBMET00613 | DBMET00613 | |
| 0.089 | 0.333 | 0.143 | Death-associated protein kinase 2 inhibitor | 0.143 0.123 DBMET01718 | DBMET01718 | |
| 0.029 | 0.275 | 0.066 | Telomerase inhibitor | 0.066 0.057 DBMET00515 | DBMET00515 | |
| 0.048 | 0.298 | 0.176 | Aldehyde dehydrogenase inhibitor | 0.145 0.05 DBMET00524 0.176 0.035 DBMET00517 | DBMET00517 | |
| 0.022 | 0.273 | 0.059 | Bombesin 1 receptor agonist | 0.059 0.043 DBMET00526 | DBMET00526 | |
| 0.038 | 0.29 | 0.139 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.102 0.052 DBMET00524 0.139 0.03 DBMET00517 | DBMET00517 | |
| 0.005 | 0.258 | 0.077 | Factor XI inhibitor | 0.058 0.007 DBMET00526 0.077 0.005 DBMET00529 | DBMET00529 | |
| 0.111 | 0.373 | 0.446 | Antibacterial | 0.418 0.069 DBMET00524 0.244 0.182 DBMET00526 0.248 0.179 DBMET00529 0.446 0.058 DBMET00517 | DBMET00517 | |
| 0.042 | 0.304 | 0.103 | Interleukin 1b antagonist | 0.103 0.077 DBMET00643 | DBMET00643 | |
| 0.045 | 0.309 | 0.176 | Electron transport complex I inhibitor | 0.176 0.012 DBMET00643 | DBMET00643 | |
| 0.015 | 0.279 | 0.039 | Phenylethanolamine N methyltransferase inhibitor | 0.039 0.031 DBMET00520 | DBMET00520 | |
| 0.014 | 0.282 | 0.074 | Protein 50S ribosomal subunit inhibitor | 0.074 0.022 DBMET00524 0.072 0.023 DBMET00517 | DBMET00524 | |
| 0.009 | 0.282 | 0.133 | Factor XIa inhibitor | 0.056 0.014 DBMET00526 0.133 0.004 DBMET00529 | DBMET00529 | |
| 0.031 | 0.326 | 0.113 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.113 0.107 DBMET00526 | DBMET00526 | |
| 0.011 | 0.321 | 0.316 | Phosphodiesterase 4D inhibitor | 0.316 0.005 DBMET00529 | DBMET00529 | |
| 0.099 | 0.434 | 0.225 | Caspase 3 stimulant | 0.225 0.137 DBMET00524 | DBMET00524 | |
| 0.066 | 0.432 | 0.228 | Hypoglycemic | 0.228 0.091 DBMET00524 0.191 0.121 DBMET00517 | DBMET00524 | |
| 0.034 | 0.401 | 0.613 | Angiogenesis stimulant | 0.585 0.007 DBMET00524 0.613 0.006 DBMET00517 | DBMET00517 | |
| 0.011 | 0.394 | 0.059 | H+/K+-transporting ATPase inhibitor | 0.059 0.026 DBMET00613 | DBMET00613 | |
| 0.065 | 0.461 | 0.189 | Lipocortins synthesis antagonist | 0.135 0.13 DBMET00519 0.189 0.064 DBMET00526 0.155 0.098 DBMET00527 0.149 0.107 DBMET00517 | DBMET00526 | |
| 0.117 | 0.523 | 0.449 | Calcium channel L-type activator | 0.393 0.086 DBMET00519 0.279 0.175 DBMET00520 0.449 0.051 DBMET00526 0.367 0.105 DBMET00643 0.364 0.107 DBMET00529 0.257 0.197 DBMET00517 | DBMET00526 | |
| 0.005 | 0.413 | 0.495 | Raf kinase C inhibitor | 0.495 0.004 DBMET01718 | DBMET01718 | |
| 0.058 | 0.467 | 0.11 | Sphingosine 1-phosphate receptor 2 agonist | 0.11 0.074 DBMET00519 | DBMET00519 | |
| 0.048 | 0.464 | 0.231 | Hepatoprotectant | 0.231 0.05 DBMET00524 0.214 0.057 DBMET00517 | DBMET00524 | |
| 0.016 | 0.437 | 0.276 | Topoisomerase I inhibitor | 0.261 0.015 DBMET00524 0.276 0.013 DBMET00517 | DBMET00517 | |
| 0.009 | 0.435 | 0.043 | Kallikrein inhibitor | 0.043 0.038 DBMET00529 | DBMET00529 | |
| 0.026 | 0.454 | 0.186 | Thioredoxin inhibitor | 0.186 0.01 DBMET00613 0.151 0.017 DBMET00643 | DBMET00613 | |
| 0.052 | 0.484 | 0.213 | Angiogenesis inhibitor | 0.213 0.155 DBMET00527 | DBMET00527 | |
| 0.069 | 0.513 | 0.227 | Sodium/bile acid cotransporter inhibitor | 0.227 0.154 DBMET00527 | DBMET00527 | |
| 0.037 | 0.486 | 0.121 | Histone deacetylase SIRT1 inhibitor | 0.121 0.089 DBMET00526 | DBMET00526 | |
| 0.004 | 0.455 | 0.028 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.02 DBMET00527 | DBMET00527 | |
| 0.031 | 0.482 | 0.205 | Platelet antagonist | 0.182 0.115 DBMET00524 0.152 0.142 DBMET00613 0.205 0.097 DBMET00643 0.186 0.112 DBMET00527 0.175 0.122 DBMET00517 | DBMET00643 | |
| 0.005 | 0.485 | 0.072 | Antineoplastic antibiotic | 0.072 0.063 DBMET00517 | DBMET00517 | |
| 0.017 | 0.502 | 0.093 | Estrogen receptor beta antagonist | 0.093 0.078 DBMET01718 | DBMET01718 | |
| 0.004 | 0.495 | 0.023 | Adenosine A3 receptor agonist | 0.023 0.007 DBMET00524 0.023 0.007 DBMET00517 | DBMET00517 | |
| 0.024 | 0.54 | 0.193 | Interleukin antagonist | 0.193 0.088 DBMET00643 | DBMET00643 | |
| 0.024 | 0.55 | 0.086 | Thioredoxin reductase inhibitor | 0.086 0.048 DBMET00613 0.077 0.07 DBMET00643 | DBMET00613 | |
| 0.015 | 0.542 | 0.062 | Factor IXa inhibitor | 0.062 0.025 DBMET00529 | DBMET00529 | |
| 0.01 | 0.543 | 0.128 | Nitric oxide donor | 0.128 0.003 DBMET00613 0.127 0.003 DBMET00643 | DBMET00613 | |
| 0.028 | 0.594 | 0.312 | Platelet adhesion inhibitor | 0.312 0.03 DBMET00524 0.299 0.034 DBMET00517 | DBMET00524 | |
| 0.011 | 0.58 | 0.038 | Antibiotic Aminoglycoside-like | 0.038 0.023 DBMET00524 0.036 0.025 DBMET00643 0.037 0.025 DBMET00517 | DBMET00524 | |
| 0.005 | 0.575 | 0.068 | Selectin antagonist | 0.066 0.045 DBMET00524 0.068 0.044 DBMET00517 | DBMET00517 | |
| 0.016 | 0.587 | 0.164 | Thrombolytic | 0.164 0.072 DBMET00524 0.141 0.089 DBMET00613 0.148 0.084 DBMET00643 0.156 0.078 DBMET00517 | DBMET00524 | |
| 0.025 | 0.598 | 0.132 | Nitric oxide antagonist | 0.132 0.116 DBMET00524 | DBMET00524 | |
| 0.001 | 0.584 | 0.02 | Purinergic P2 agonist | 0.019 0.007 DBMET00524 0.02 0.007 DBMET00517 | DBMET00517 | |
| 0.001 | 0.584 | 0.02 | Purinergic receptor agonist | 0.019 0.007 DBMET00524 0.02 0.007 DBMET00517 | DBMET00517 | |
| 0.009 | 0.615 | 0.042 | Purinergic P2Y2 antagonist | 0.042 0.015 DBMET00524 0.041 0.015 DBMET00517 | DBMET00524 | |
| 0.022 | 0.641 | 0.27 | DNA polymerase I inhibitor | 0.229 0.021 DBMET00524 0.27 0.014 DBMET00517 | DBMET00517 | |
| 0.001 | 0.629 | 0.015 | Purinergic P2Y agonist | 0.014 0.007 DBMET00524 0.015 0.007 DBMET00517 | DBMET00517 | |
| 0.012 | 0.666 | 0.208 | Free radical scavenger | 0.18 0.115 DBMET00524 0.208 0.091 DBMET00613 0.154 0.141 DBMET00643 0.153 0.142 DBMET00517 | DBMET00613 | |
| 0.003 | 0.672 | 0.043 | Adenosine A1 receptor agonist | 0.043 0.007 DBMET00524 0.042 0.007 DBMET00517 | DBMET00524 | |
| 0.01 | 0.681 | 0.126 | Aminoacyl-tRNA synthetase inhibitor | 0.126 0.027 DBMET00524 0.12 0.03 DBMET00517 | DBMET00524 | |
| 0.025 | 0.703 | 0.144 | Interleukin 4 antagonist | 0.144 0.056 DBMET00643 | DBMET00643 | |
| 0.02 | 0.7 | 0.123 | Interleukin 5 antagonist | 0.123 0.022 DBMET00643 | DBMET00643 | |
| 0.006 | 0.724 | 0.068 | Maillard reaction inhibitor | 0.068 0.03 DBMET00643 | DBMET00643 | |
| 0.027 | 0.748 | 0.418 | Cyclophilin D inhibitor | 0.418 0.081 DBMET00524 0.4 0.091 DBMET00517 | DBMET00524 | |
| 0.011 | 0.733 | 0.196 | Antioxidant | 0.196 0.117 DBMET00524 0.188 0.124 DBMET00517 | DBMET00524 | |
| 0.005 | 0.728 | 0.063 | CDC25B inhibitor | 0.063 0.046 DBMET00613 | DBMET00613 | |
| 0.011 | 0.735 | 0.127 | Dual specificity phosphatase inhibitor | 0.127 0.125 DBMET00613 | DBMET00613 | |
| 0.003 | 0.75 | 0.04 | Prostaglandin D2 agonist | 0.04 0.013 DBMET00643 | DBMET00643 | |
| 0.023 | 0.785 | 0.083 | Transcription factor NF kappa B stimulant | 0.083 0.063 DBMET00524 0.083 0.062 DBMET00517 | DBMET00517 | |
| 0.003 | 0.829 | 0.017 | Adenosine A2b receptor agonist | 0.017 0.007 DBMET00524 0.017 0.008 DBMET00517 | DBMET00517 | |
| 0.012 | 0.868 | 0.061 | Adenine nucleotide translocase inhibitor | 0.061 0.027 DBMET00524 0.061 0.026 DBMET00517 | DBMET00517 | |
| 0.002 | 0.88 | 0.02 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.02 0.014 DBMET00524 0.02 0.014 DBMET00517 | DBMET00517 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |